























































































ribosomal	 oxygenases	 (ROXs).	 ROXs	 have	 emerged	 as	 enzymes	 that	 affect	 translation	 by	
hydroxylation	 of	 translation	 factors	 like	 the	 eukaryotic	 release	 factor	 eRF11,	 tRNA2,3,	 or	
ribosomal	 proteins.	 Bacterial	 ancestor	 ycfD,	 mammalian	 OGFOD1,	 Myc-induced	 nuclear	




generating	 knockout	 strains	 and	 CRISPR/Cas9	 knockout	 cell	 lines,	 respectively,	 and	
examining	 those	 in	 growth	 behaviour	 and	 with	 regard	 to	 ribosome	 composition.	 Hereby,	




Identification	 and	 characterization	 of	 the	 interaction	 with	 cell	 cycle	 regulator	 CCNA2	
connects	 OGFOD1	 to	 the	 cell	 cycle.	 OGFOD1	 knockout	 was	 not	 viable	 in	 cells,	 further	




MINA53	 and	 NO66	 share	 several	 similarities	 in	 substrate	 specificity,	 domain	 architecture,	
and	 subcellular	 localization.	 As	 homo-oligomerization	 seemed	 to	 emerge	 as	 a	 common	
feature	 of	 2OG	 oxygenases,	 the	 function	 of	 the	 oligomerization	 of	 both	 proteins	 was	
analyzed	in	more	detail	with	regard	to	substrate	binding.	Indeed,	disruption	of	dimerization	
caused	 a	 loss	 of	 interaction	 of	 NO66	 with	 its	 substrate	 RPL8.	 Phylogenetic	 studies	 were	










abhängigen	 Oxygenasen	 (2OG	 Oxygenasen)	 definiert.	 Diese	 beeinflussen	 die	 Translation	
durch	 Hydroxylierung	 von	 ribosomalen	 Proteinen,	 dem	 eukaryotischen	 „release	 factor“	
eRF11	 und	 tRNA2,3.	 Bakterielles	 ycfD,	 humane	 Proteine	 OGFOD1,	 „Myc-induced	 nuclear	
antigen“	(MINA53)	und	NO66	haben	ribosomale	Proteine	als	Substrat4-6.	
	
In	 dieser	 Arbeit	 wurden	 ycfD	 und	 die	 humanen	 Homologe	 OGFOD1,	 MINA53	 und	 NO66	
charakterisiert.	 Hierfür	 wurde	 ein	 bakterieller	 Knockout-Stamm	 für	 ycfD	 und	 für	 die	
humanen	 Proteine	 CRISPR/Cas9	 Knockout	 Zelllinien	 hergestellt	 und	 im	 Hinblick	 auf	
Wachstum	und	ihre	Ribosomen	untersucht.	Anhand	von	LC-MS/MS	konnten	die	publizierten	
ribosomalen	Substrate	von	MINA53	und	NO66	bestätigt	werden.	Zusätzlich	können	mit	den	
produzierten	 massenspektrometrischen	 Daten	 neue	 Modifikationen	 an	 ribosomalen	
Proteinen	 identifiziert	 werden.	 Knockout	 von	 ycfD	 hingegen	 hatte	 keinen	 Effekt	 auf	
Wachstum	oder	ribosomales	Profil.	
	
Zellzyklusregulator	 CCNA2	 wurde	 als	 neuer	 Interaktionspartner	 von	 OGFOD1	 identifiziert	
und	 charakterisiert.	 Eine	 Verbindung	 der	 ribosomalen	 Oxygenase	 OGFOD1	 mit	 dem	
Zellzyklus	 kann	 auch	 hergestellt	 werden,	 da	 Knockout-Zellen	 von	 OGFOD1	 nicht	





kristallisierte	 sich	 Oligomerisierung	 als	 eine	 verbreitete	 Eigenschaft	 von	 2OG	 Oxygenasen	
heraus.	Deshalb	wurde	die	Funktion	der	Oligomerisierung	von	MINA53	and	NO66	im	Hinblick	
auf	 Substratbindung	 näher	 analysiert.	 Mutations-	 und	 Deletionsmutanten	 in	 der	
Dimerisierungsdomäne	 führten	 auch	 zu	 verhinderter	 Substratbindung	 bei	 NO66.	 Zudem	
wurde	anhand	von	phylogenetischen	Untersuchungen	die	Evolution	beider	Proteine	verfolgt.	
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of	 the	 hypoxic	 response	 assigned	 them	 important	 roles	 in	 the	 cell.	 More	 recently,	
investigations	in	the	epigenetic	field	defined	a	subgroup	of	2OG	oxygenases	as	histone,	DNA,	
and	RNA	modifying	proteins.	With	ongoing	research	to	elucidated	the	roles	of	the	many	not	
yet	 characterized	 2OG	 oxygenases,	 the	 subfamiliy	 of	 ribosomal	 oxygenases	 (ROXs)	 was	
discovered.	These	enzymes	seem	to	regulate	gene	expression	at	the	level	of	translation.	 In	
this	 thesis,	 bacterial	 ancestor	 ycfD	 and	 its	 human	 homologues	 OGFOD1,	 Myc-induced	
nuclear	antigen	(MINA53)	and	NO66	were	studied	in	more	detail.	
	
1.1 Translation	 and	 its	 regulation	 by	 post-translational	
modifications	
1.1.1 The	ribosome	and	translation	
The	 ribosome	 is	 a	 huge	 protein-RNA	 complex	 responsible	 for	 the	 translation	 of	 genes	
encoded	on	messenger	RNA	(mRNA)	into	polypeptide	chains.		
Deciphering	 the	mRNA	code	 is	 carried	out	by	 the	 codon:anticodon	helix	 formed	by	mRNA	
and	transfer	RNA	(tRNA)	in	the	decoding	site	of	the	ribosome.	
Translation	always	follows	a	certain	succession	of	events.	It	starts	with	the	small	ribosomal	
subunit	 binding	 to	 the	 5’	 untranslated	 region	 (UTR)	 of	 the	 mRNA	 and	 scanning	 for	 a	
translation	 start	 side	 on	 the	 mRNA.	 Once	 the	 start	 codon	 AUG	 is	 found,	 three	 initiation	
factor	proteins	bind	to	the	small	subunit	as	well	as	the	initiator	tRNA	methionine	responsible	
for	 decoding	 AUG.	 Thereby	 the	 initiation	 complex	 is	 formed.	 Now	 the	 large	 ribosomal	
subunit	can	bind,	which	results	in	the	release	of	the	initiation	factors.	






the	E	 (exit)	 position,	 the	 tRNA	gets	 released	back	 into	 the	 cytoplasm	where	 it	 is	 recycled.	
Delivery	of	amino	acids	by	tRNAs	drives	the	elongation	of	the	protein.	The	stop	codon	on	the	





core-ribosome	protein	composition	seems	to	be	distinct	 in	different	 tissues	and	cell	 types,	
also	the	ribo-actome	or	different	translation	factors	with	manifold	modifications	contribute	
to	a	new	field	of	gene	expression	on	the	post-transcriptional	level.	
Dependent	 on	 cell	 type,	 developmental	 stage	 or	 as	 reactions	 to	 changing	 environmental	












Many	 of	 the	 discovered	 and	 studied	 modifications	 are	 involved	 in	 different	 steps	 of	
ribosome	maturation	and	assembly.	For	 instance,	 the	 loss	of	 the	methylation	of	L3	 (uL317)	








rRNA,	 there	 are	 also	 reports	 of	 PTMs	 on	 the	 ribosome	 affecting	 translation	 directly.	 One	
example	 is	 the	 hydroxylated	 Pro62	 in	 human	 RPS23	 (uS12).	 This	 residue	 is	 located	 in	 the	
PNSA	loop	which	is	part	of	the	platform	for	the	codon:anticodon	minihelix19.	Proline	62	gets	










So	 far	 there	are	 six	2OG	oxygenases	 found	 in	bacteria4,	 in	humans	more	 than	60	proteins	
were	identified21-24.	
Substrates	 are	 manifold	 including	 proteins,	 RNA,	 and	 DNA17,19.	 Therefore	 the	 functional	
range	 of	 2OG	 oxygenases	 in	 mammalians	 covers	 various	 different	 processes	 in	 the	 cell.	
Additional	domains	 like	zink	 finger	domains	 for	DNA	binding	or	protein-protein	 interaction	
domains	contribute	to	their	substrate	specificity23.	
The	 family	 classifying	 feature	 is	 the	 double-stranded	 β-helix	 (DSBH)	 domain	 (Jumonji-C	
(JmjC),	cupin,	or	jelly-roll	domain).	It	consists	of	two	sheets	of	four	β-helices	opposing	each	
other	to	form	a	barrel	like	structure.	Inside	the	barrel,	three	amino	acids	build	the	catalytic	













In	 addition	 to	 the	 oxidation	 of	 proteins	 or	 tRNA	 leading	 to	 stably	 hydroxylated	 residues,	
demethylation	is	another	product	of	some	of	the	2OG	oxygenases.	Demethylation	occurs	as	
a	 two	 step	 reaction,	 starting	 with	 hydroxylation	 of	 a	 Nε-methyl	 group	 followed	 by	











by	 asparaginyl	 hydroxylase	 FIH	 (factor	 inhibiting	 HIF-1)	 targets	 HIF1α	 for	 proteasomal	
degradation.	 Low	 oxygen	 levels	 inhibit	 the	 asparaginyl	 hydroxylase	 FIH	 as	 it	 needs	






2OG	 oxygenases	 emerged	 as	 major	 players	 in	 epigenetic	 regulation.	 More	 than	 20	 2OG	
oxygenases	act	as	histone	lysine	demethylases	(KDMs),	like	the	JARID	family	or	JMJD2	a-d30.	
Additionally,	 the	 Tet	 subfamily	 (Tet1,	 Tet2,	 and	 Tet3)	 catalyses	 the	 oxidation	 of	 5-
methylcytosine	 to	 5-hydroxymethylcytosine	 in	 DNA31-33.	 FTO,	 member	 of	 the	 AlkB	
homologue	(AlkBH)	subfamily	demethylates	the	N6-methyladenosine	in	mRNA34.	TYW5	and	





transcriptional,	 translational,	 and	 post-translational	 processes;	 (ALKBH	 stands	 for	 alkylated	 DNA	 repair	
protein	alkB	homolog;	TET1–3,	ten-eleven	translocation	1–3;	FTO,	fat	mass-	and	obesity-associated	protein;	
TYW5,	 tRNA	 wybutosine-synthesizing	 protein	 5;	 C-P4Hs,	 collagen	 prolyl	 4-hydroxylases;	 C-P3Hs,	 collagen	






related	 proteins	 indicates	 a	 novel	 type	 of	 translation	 regulation4,6.	 These	 ribosomal	
oxygenases	 (ROXs)	are	conserved	 from	bacteria	 to	eukaryotes.	 In	bacteria	ycfD	 is	 the	only	
ribosomal	 oxygenase,	 in	 human	 six	 enzymes,	 ALKBH8,	 TYW5,	 JMJD4,	MINA53,	 NO66,	 and	
OGFOD1	(Figure	4)	were	subclassified	as	ROXs38,39.	
	








Figure	 4:	 Human	 2-Oxoglutarate	 oxygenases	 targeting	 translation	 by	 hydroxylating	 ribosomal	 protein,	
translation	factors	or	tRNA.	Adapted	from	Ploumakis	et	al43.	
	
Recently,	 Jmjd4	was	 identified	 to	hydroxylate	 a	 lysine	 in	 the	NIKS	motif	 of	 the	 translation	
release	factor	eRF11.	This	motif	is	responsible	for	optimal	translation	termination.	
	






spectrometry45.	 In	 addition	 to	 several	 methylated	 and	 acetylated	 proteins,	 the	 authors	
mentioned	an	„unknown“	modification	in	ribosomal	protein	L16	(RPL16,	uL1617)	at	arginine	
81	 (R81)45.	 Some	 years	 later,	 interaction	 of	 ycfD	 with	 RPL16	 was	 identified	 using	




suggested	 that	 ycfD-binding	 occurs	 with	 RPL16,	 which	 is	 not	 incoorporated	 into	 the	
ribosome46.		
R81	of	RPL16	 is	 located	 in	closest	proximity	to	the	peptidyl	 transferase	center	 (PTC)	 in	the	
large	 ribosomal	 subunit	 (Figure	 5).	 RPL16	 is	 essential	 for	 the	 association	 of	 the	 large	 and	
small	 subunit	 to	 form	 the	 70S	 initiation	 complex47.	 In	 addition,	 it	 is	 important	 for	 the	
peptidyl	 transferase	activity48	 and	 seems	 to	 stabilize	 the	binding	of	A-site	 tRNA49.	Hereby,	





















histidine	 residues	 (H);	MINA53	hydroxylates	H39	of	 the	 ribosomal	proteins	RPL27a	 (uL15),	











mRNA	 expression	was	 upregulated	 in	 alveolar	macrophages	 from	 coal	miners	 exposed	 to	




TH2	 development.	 MINA53	 was	 found	 to	 act	 as	 genetic	 determinant	 of	 the	 TH2	 bias	 by	
binding	 the	 interleukin	 4	 (IL-4)	 promoter	 and	 regulating	 IL4	 levels72.	 In	 mice,	 MINA53	

























































particles51.	 However,	 another	 field	 of	 intensive	 research	 about	 NO66	 focuses	 on	 the	
regulation	 of	 the	 osteoblast-specific	 transcription	 factor	 Osterix.	 Osterix	 is	 essential	 for	
osteoblast	 differentiation	 and	 bone	 formation	 and	 was	 shown	 to	 interact	 directly	 with	
NO66.	 Additionally	 NO66	 seemed	 to	 inhibit	 Osterix	 promoter	 activity79-82.	 In	 this	 context,	
NO66	was	shown	to	demethylate	H3K4me3	and	H3K36me3	and	thereby	modify	the	activity	
of	 osteoblast	 specific	 promoters79,83.	 Interaction	 of	 NO66	 with	 the	 Polycomb	 repressive	
chromatin	modifier	pointed	also	towards	a	role	 in	epigenetic	regulation84.	This	 finding	was	





OGFOD1	 is	 conserved	 from	 yeast	 to	 human86-88.	 Structure-wise,	OGFOD1	 is	 a	 special	 2OG	
oxygenase	as	it	consists	of	two	barrel	like	DSBH	domains.	However,	enzymatic	activity	is	only	
carried	out	by	the	N-terminal	domain	as	it	harbours	the	essential	HxD...H	triad	to	coordinate	
























some	 stress	 granule	 proteins,	 the	 eIF2alpha	 kinase	 heme-regulated	 inhibitor	 (HRI),	 and	
eIF2alpha	 itself.	 Overexpression	 of	 OGFOD1	 resulted	 in	 decreased	 polysome	 levels	 and	
increased	amounts	of	phosphorylated	eIF2alpha	during	recovery	from	stress.	Knockdown	on	




In	a	screen	of	B	cells	and	chronic	 lymphocytic	 leukemia	 (CLL),	OGFOD1	was	 found	to	have	
higher	 transcript	 and	protein	 levels91.	 Also	 an	 involvement	 in	 cancer	was	 shown	 in	 breast	
cancer	 cells,	 OGFOD1	 displayed	 a	 high	 expression92.	 Consistent	 with	 this,	 knockdown	 in	
breast	 cancer	 cells	 led	 to	 an	 inhibiton	 of	 proliferation	 probably	 resulted	 by	 an	 observed	
G2/M	 arrest.	 Another	 suggestion	 of	 OGFOD1	 being	 involved	 in	 proliferation	 regulation	 or	





Sud1	 in	Drosophila	melanogaster	 (D.melanogaster)	 and	 Tpa1	 in	 Saccharomyces	 cerevisiae		
(S.cerevisiae)	 hydroxylate	 Pro62	 (Pro64	 in	 D.melanogaster	 and	 S.cerevisiae)	 of	 RPS23	
(uS12)5,17,20,44.	
The	human	homolog	OGFOD1	was	shown	to	hydroxylate	RPS23	at	proline	625	(Figure	9,	right	
picture).	RPS23	 in	bacteria	 (S12)	 is	 localized	 in	 the	 small	 ribosomal	 subunit	 and	builds	 the	







Figure	 9:	 H.sapiens	 80S	 ribosome	 (3J3A,	 3J3AB	 and	 3J3D),	 A-	 and	 P-site	 tRNA	 from	 T.thermophilis	 70S	
ribosome	 (PDB:	 2J02	 and	 2J03);	 crystal	 structures	 on	 the	 right	 reduced	 to	 E-,	 P-	 and	 A-site	 tRNA	 in	 blue,	
mRNA	in	yellow	and	RPS23	in	green,	by	OGFOD1	hydroxylated	proline	62	(P62)	in	red.	
	





reduced	cell	 size	and	 reduced	cell	 number.	Next	 to	a	decrease	 in	protein	 synthesis,	 stress	
granule	formation	and	activation	of	the	unfolded	protein	response	was	observed	upon	Sud1	
knockdown44,94.	
In	 a	 case	 studie	 of	 two	 patients	 suffering	 of	 microcephaly,	 hearing	 loss,	 and	 overlapping	
dysmorphic	 features,	 mutations	 in	 RPS23	 were	 identified.	 The	 severeness	 of	
ribosomopathies	 in	 human	 highlights	 the	 importance	 of	 intact	 and	 correctly	 modified	
ribosomal	proteins	in	general	and	RPS23	specifically95.	
	
S.cerevisiae	 homolog	 Tpa1	 was	 analyzed	 by	 different	 groups.	 Related	 to	 the	 function	 of	
OGFOD1	 in	 hydroxylating	 RPS23	 (uS12),	 Tpa1	 function	 in	 yeast	 seems	 to	 be	 related	 to	
translation.	Increased	readthrough	of	stop	codons	was	observed	upon	deletion	of	Tpa196	as	
well	as	decreased	translation	termination	efficacy	probably	caused	by	increased	stop	codon	
readthrough87.	 Aditionally	 interaction	 with	 the	 translation	 termination	 factors	 eRF1	 and	
eRF3	 as	 well	 as	 with	 poly(A)	 binding	 protein	 Pab1	 indicates	 a	 role	 of	 Tpa1	 in	 correct	
translation	termination96.	More	recently,	another	function	of	Tpa1	was	reported.	Related	to	





























overexpression	or	knockout.	Generation	of	knockout	 strains/cell	 lines	 should	 further	allow	
characterization	of	 the	 cell	 lines	with	 regards	 to	 their	 ribosome	 composition	 and	 changed	
PTMs	on	ribosomal	proteins.	Knockout	cell	lines	reconstituted	with	different	protein	variants	
could	help	to	characterize	those	variants	in	more	detail.	
Cell	 cycle	 regulator	 CCNA2	 should	 be	 examined	 as	 novel	 interactor	 of	 OGFOD1	 by	




and	 point	mutants	 affecting	 the	 dimerization	 domain.	 Substrate	 binding	 in	 those	mutants	
should	 be	 further	 analyzed	 by	 immunoprecipitation	 assays	 and	 with	 knockout	 cell	 lines	









The	 comercially	 available	 ycfD	 knockout	 strain	 JW1114-2103	 showed	 growth	 defects	 in	
minimal	media4.	By	generating	genomic	modified	strains	like	a	ycfD	knockout	strain,	a	strain	





















































Earlier	 studies	 showed	 that	 overexpression	 of	 His-tagged	 ycfD	 led	 to	 tremendous	 growth	




type	 strain	 was	 investigated	 under	 different	 growth	 conditions	 like	 rich	 medium	 (LB	
medium),	 minimal	 medium	 (M9)	 or	 with	 chloramphenicol	 (CAP)	 (Figure	 11	 A).	 The	 same	









With	 increasing	CAP	concentrations	 in	 the	LB	medium,	bacterial	growth	of	all	 three	tested	































































































































































Growth of BW25113  (rpsL150)
WT strain
Growth of BW25113  (rpsL150, ycfD-H125A, D127A)
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As	 this	 result	 is	 contradictory	 to	 the	observed	 growth	defects	 of	 the	 ycfD	 knockout	 strain	
JW11144,	this	strain	was	also	included	in	the	growth	assay.	Contrary	to	the	published	data,	
no	growth	phenotyp	of	ycfD	defective	strains	could	be	observed	as	neither	BW25113,	nor	





Figure	 13:	 Bacterial	 growth	 of	 different	 strains	 at	 25°C	 in	 LB	 medium	 for	 22h;	 BW25113	 and	 BW25113	
(rpsL150)	as	wild	type	control	and	JW1114	were	grown	in	either	LB	medium	or	M9	minimal	medium.	
Therefore,	 no	 growth	deficiency	of	 bacteria	 lacking	 ycfD	 (JW1114),	 lacking	 ycfD	 in	 nts	 51-
1071	 (BW25113	 (rpsL150,	 ycfD-neo/kan-cassette),	 or	 BW25113	 (rpsL150,	 ycfD-
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Ribosomes	 of	 the	 different	 aforementioned	 bacterial	 strains	 have	 also	 been	 analyzed	 (in	
collaboration	 with	 Daniel	 Wilson's	 Lab,	 Gene	 Center	 Munich	 with	 the	 help	 of	 Dr.	 Agata	





40%	 sucrose	 gradient.	 Following	 ultracentrifugation,	 the	 gradients	 were	 fractionated	 from	 top	 to	 bottom	




The	 first	 peak	 is	 A260	 absorbing	material,	 containing	 no	 ribosomes.	 The	 second	 and	 third	
peaks	 correspond	 to	 the	 small	 (30S)	 and	 the	 large	 ribosomal	 subunits	 (50S).	 The	 largest	
amount	of	ribosomes	appears	as	monosomes	(70S	peak).	Ribosomes	associated	with	mRNA	
appear	in	several	peaks	(polysome	peaks).	Differences	in	peak	size	or	complete	loss	of	one	
ribosomal	 fraction	 in	 the	 gradient	 indicate	 assembly	 defects	 or	 variations	 in	 translation	
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wild	 type.	 Also	 ribosome	 profiles	 of	 the	 corresponding	 strains	 resulted	 in	 no	 detectable	





















could	precipitate	CCNA2,	 as	 the	 signal	 from	 the	eluted	protein	 in	 the	 „Beads“	 fraction	 (B)	
was	 detectable	 (Figure	 15	 B).	 This	 antibody	 binds	 CCNA2	 quite	 efficiently,	 as	 not	 much	











OGFOD1	 interaction	with	CCNA2	 can	be	 shown	on	endogenous	 level,	 as	OGFOD1	with	 75	
kDa	 is	 detected	 in	 the	 CCNA2	 IP	 samples	 and	 therefore	 got	 co-precipitated	 with	 CCNA2	
(Figure	15	B,	anti-OGFOD1	staining).	Notably,	with	anti-OGFOD1	staining,	there	is	a	second	
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3µg α-CCNA2  (C4710)C




























anti-OGFOD1	 staining,	 B).	 The	 100	 kDa	 band	was	 already	 reported	 before	 as	 high-affinity	















were	 lysed	 and	 mixed	 with	 lysates	 with	 His-OGFOD1;	 CCNA2,	 OGFOD1,	 and	 GFP	 were	 detected	 with	
indicated	antibodies	in	subsequent	Western	blotting.	I=Input,	F=	Flowthrough,	B=	Beads	fraction	
	
To	 determine,	 if	 CCNA2	 in	 complex	 with	 CDK1	 or	 CDK2	 is	 bound	 by	 OGFOD1,	 co-
immunoprecipitation	of	CDK1	and	CDK2	with	CCNA2	and	OGFOD1	was	tested.	Therefore,	IP	
of	 CCNA2,	 OGFOD1,	 CDK1,	 and	 CDK2,	 was	 performed	 with	 subsequent	Western	 blotting.	
First,	interaction	of	CCNA2	with	OGFOD1	and	vice	versa	could	be	confirmed	(Figure	17,	A	and	
B).	Binding	of	CCNA2	to	OGFOD1	is	specific,	as	cell	cycle	protein	Cyclin	B1	(CCNB1)	can	not	
be	 detected	 in	 OGFOD1	 IP	 samples	 (Figure	 17	 B).	 CCNA2	 IP	 results	 in	 co-precipitation	 of	
OGFOD1,	CDK1	and	CDK2	(Figure	17	A).	
However,	 the	 interaction	 of	OGFOD1	with	 CCNA2	 seems	 to	 be	 direct	 and	 not	 in	 complex	





























Figure	 17:	 Interaction	 of	 CCNA2	 and	 OGFOD1	 does	 not	 occur	 in	 complex	 with	 CDK2	 or	 CDK1;	 Protein	 G	
Sepharose	beads	are	pre-incubated	with	A)	anti-CyclinA,	B)	anti-OGFOD1,	C)	anti-CDK2,	D)	anti-CDK1,	and	E)	





and	 CDK2.	 For	 these	 experiments,	 bacterial	 lysates	 expressing	 GFP-CCNA2	 was	 first	
incubated	 with	 untagged	 OGFOD1	 and	 subsequently	 with	 His-tagged	 CDK2	 or	 vice	 versa.	
Direct	 CCNA2-binding	 could	 again	 be	 deteceted	 (Figure	 18	 B	 and	 C).	 Established	 CDK2-
CCNA2	 inhibited	 additional	 OGFOD1-CCNA2	 interaction	 (Figure	 18	 E).	 OGFOD1-CCNA2	
complex	 formation	 allowed	 additional	 binding	 of	 CCNA2	 and	 CDK2	 (Figure	 18	 D).	 In	 the	
negative	control	neither	OGFOD1	nor	His-CDK2	can	be	detected	in	the	IP	lane	(Figure	18	F).	
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lysates;	 GFP-CCNA2,	 OGFOD1,	 His-CDK2,	 and	 GFP	were	 detected	with	 indicated	 antibodies	 in	 subsequent	
Western	blotting.	I=Input,	F=	Flowthrough,	B=	Beads	fraction	
	
Interaction	 of	 CCNA2	 and	 OGFOD1	 could	 be	 shown	 by	 another	 independent	 interaction	
assay,	the	fluorescent-2-hybrid	(F2H)	assay.	In	this	assay,	genetically	modified	baby	hamster	




Known	 interaction	 partner	 of	 OGFOD1,	 ribosomal	 protein	 RPS235,	 was	 used	 as	 positive	











   I        F      B            
GFP-CCNA2+OGFOD1








   I        F      B            
GFP-CCNA2+His-CDK2




















































2.2.1.2 In	 vivo	 and	 in	 vitro	 studies	 to	 identify	 OGFOD1	 and	 CCNA2	 interaction	
domains	







Figure	 20:	 Schematic	 drawing	 of	 OGFOD1	 domain	 structure	 and	 generated	 mutants;	 nuclear	 localization	
signal	(NLS)	is	colored	in	gray,	DSBH	domains	in	blue,	mutated	amino	acids	are	indicated	in	red.	
Wild	type	OGFOD1	exhibits	the	catalytically	active	N-terminal	DSBH	domain	containing	the	
iron	 coordinating	 HxD...H	motif	 and	 a	 C-terminal	 DSBH	 lacking	 the	 iron-binding	motif.	 N-
terminal	 and	 C-terminal	 DSBH	 domains	 are	 separated	 by	 a	 linker	 sequence.	 The	 very	 N-
terminal	 nuclear	 localization	 signal	 (NLS)	 causes	 the	 nuclear	 localization	 of	 the	 protein	
(Figure	 20	 A).	 The	 OGFOD1	 AxA	 variant	 has	 a	 mutated	 iron	 binding	 motif,	 histidine	 155	
(H155)	 and	 aspartic	 acid	 (D157)	 are	 changed	 to	 alanine	 (A)	 (Figure	 20	 B)	 and	 is	 thereby	
catalytically	 inactive5.	 RxL	 motifs	 were	 identified	 to	 be	 responsible	 for	 CCNA2	 binding	 to	
substrates	 like	cyclin-dependent	kinase	inhibitor	1B	or	CDK-Inhibitor	1106,107.	One	RxL	motif	
was	 identified	 in	OGFOD1	and	mutated	 (arginine	519	 (R519)	 and	 leucine	521	 (L521)	 to	A)	
(Figure	20	C).	












































C-terminal DSBHOGFOD1 Δ1-30 
= aa 31-542H
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proteins	 as	 indicated;	 F)	MINA53-GFP	was	used	 as	 control;	OGFOD1-GFP	and	mutants,	MINA53-GFP,	 Flag-
tagged	 CCNA2,	 and	 endogenous	 CCNA2	 were	 detected	 with	 indicated	 antibodies	 in	 subsequent	Western	
blotting.	I=Input,	F=	Flowthrough,	B=	Beads	fraction	
Anti-GFP-IP	 of	 OGFOD1-GFP	 co-precipitated	 Flag-tagged	 CCNA2,	 as	 confirmed	 with	 Flag	
antibody	 staining	 in	 Western	 blot	 (Figure	 21	 B).	 Also	 OGFOD1	 iron	 binding	 mutant	 AxA	
showed	 interaction	with	 Flag-tagged	CCNA2	 (Figure	21	C).	 The	OGFOD1	mutant	 1-260	did	
bind	to	CCNA2	(Figure	21	D)	whereas	the	mutant	lacking	those	amino	acids	(OGFOD1	aa	1-43	







proteins	 as	 indicated;	 OGFOD1-GFP	 and	 mutants	 and	 Flag-tagged	 CCNA2	 were	 detected	 with	 indicated	
antibodies	in	subsequent	Western	blotting.	I=Input,	F=	Flowthrough,	B=	Beads	fraction	
Both	mutants	 lacking	 the	NLS	sequence	still	 interacted	with	OGFOD1.	OGFOD1	 lacking	 the	
first	 20	 amino	 acids	 (Figure	 22	 Blot	 B)	might	 show	 a	 reduced	 ability	 to	 interact,	 whereas	
OGFOD1	 lacking	 amino	 acids	 1-30	 interacted	 comparable	 to	 wild	 type	 (Figure	 22	 Blot	 C).	






























































































Mutation	 of	 a	 putative	 CCNA2	 interaction	 motif	 (OGFOD1	 RxL)	 also	 showed	 no	 reduced	
binding	capacity	(Figure	22	Blot	D).	Also,	the	 linker	connecting	both	DSBHs	of	OGFOD1	did	


























In	 an	 in	 vitro	 approach	with	 recombinant	 protein,	 I	 was	 not	 able	 to	 confirm	 this	 binding	
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contrary	 to	 the	 aforementioned	 cell-based	 assays,	 the	 CCNA2	 mutant	 1-180	 exhibited	 a	





or	 mutants	 and	 untagged	 OGFOD1.	 Lysates	 of	 GFP-tagged	 proteins	 were	 preincubated	 with	 GFP-Trap_A	





These	 experiments	 indicated,	 that	 the	 N-terminal	 DSBH	 in	 OGFOD1	 is	 crucial	 for	 CCNA2	
binding	 independently	 of	 catalytic	 activity.	 For	 CCNA2,	 no	 OGFOD1	 biding	 domain	 was	
identified	with	certainty.	
	
2.2.1.3 Investigations	 to	 identify	 hydroxylated	 prolines	 in	 CCNA2	 modified	 by	
OGFOD1	
After	having	confirmed	OGFOD1-CCNA2	binding	with	different	assays,	CCNA2	was	examined	
in	 regard	 to	 being	 an	 OGFOD1	 substrate.	 Online	 prediction	 programs	 suggested	 different	
prolines	of	CCNA2	to	be	hydroxylated	(see	Table	1).	iHyd-PseAAC	offered	P155	and	P402	as	





iHyd-PseAAC	 	 	 P155	 	 	 P402	
PredHydroxy	 	 	 	 	 	 P402	
RF-
Hydroxysite	
P89	 P135	 	 P195	 P273	 	
Table	1:	Online	proline	hydroxylation	programs	used	for	prediction	of	CCNA2	proline	hydroxylations;	in	gray	
identified	 potenial	 proline	 hydroxylation	 sites	 with	 low	 probability	 and	 significance,	 in	 black	 with	 higher	
significance;	searches	were	performed	25.08.2016.	






















with bacterial lysates 
expressing either:
- GFP-CCNA2 WT 
























(LC-MS/MS)	 was	 used.	 Different	 experimental	 set-ups	 were	 exhibited	 to	 circumvent	 low	
protein	 coverages.	 Endogenous	 protein,	 overexpressed	 3xFlag-CCNA2,	 and	 recombinant	
GST-CCNA2	 were	 immunoprecipitated	 (Table	 2)	 and	 analyzed	 by	 label-free	 LC–MS/MS	
(Juliane	 Merl-Pham,	 Stefanie	 Hauck,	 HelmholtzZentrum	 München).	 Hydroxylated	 prolines	








hydroxylated	 prolines	 were	 also	 suggested	 in	 samples	 containing	 only	 GST-CCNA2.	
Depending	 on	 experiment,	 different	 hydroxylated	 prolines	 were	 identified	 or	 even	 none	
(endogenous	 IP,	 Table	 2),	 therefore	 no	 reliable	 hydroxylation	 could	 be	 detected	 with	 LC-
MS/MS.	
Protein	coverage	of	CCNA2	in	the	three	experiments	ranged	from	41-60%.	Therefore,	several	
peptides	 with	 potential	 hydroxylation	 sites	 were	 not	 detected	 (Figure	 26	 A).	 However,	
attempts	 to	 increase	 CCNA2	 coverage	 by	 combined	 digest	with	 Chymotrypsin/Trypsin	 did	
not	result	in	higher	protein	coverages	(data	not	shown).	
	













































Here	 we	 generated	 peptides	 spanning	 prolines,	 which	 were	 suggested	 by	 preceding	 LC-








and	with	 OGFOD1	 addition;	 Reaction	 Conditions:	 7.7	 µM	 recombinant	 OGFOD1,	 50	 µM	 peptide,	 300	 µM	
2oxoglutarate,	100	µM	Fe(II),	and	1mM	Ascorbate;	reaction	was	incubated	for	3h	at	RT	and	quenched	with	
formic	acid.	
D-Box Cyclin box 1 432Cyclin box 21CCNA2 coverage 
MLGN...LQEDQEN INPOHEKAAPV  ...  VNDEHV TVPOHPOHWKANS   ...  AQK KPOHAESQKIE  ...  AFNSAISLPOHGPOHRKPLVPL   ...  LHQTYLKAPOHQHAQQSIR EKY   ...  TLNL*
35 88 89 114 135 137 402
AFNSAISLPGPRKPLVPLDY
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CCNA2    EAEKEAQKKPAESQKIERED
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pattern.	 Additionally,	 Hek293T	 cells	 were	 synchronized	 and	 expression	 levels	 of	 OGFOD1	
through	 the	 cell	 cycle	 were	 checked	 using	 western	 blot.	 Also	 interaction	 of	 CCNA2	 and	
OGFOD1	 throughout	 the	 cell	 cycle	was	monitored.	 Furthermore,	 cell	 cycle	 progression	 of	






line	 stably	 expressing	 a	RFP-tagged	nano-antibody	 against	 endogenous	PCNA115	was	used.	
Proliferating	cell	nuclear	antigen	(PCNA)	localization	provides	a	precise	marker	for	S	phases	
as	 it	 is	 a	 helping	 factor	 for	DNA	 synthesis	 during	 replication.	With	 starting	 S	 phase,	 PCNA	






















Figure	29:	Distribution	of	OGFOD1	during	 the	 cell	 cycle	 in	HeLa	 chromobody	 (Chromotek)	 cells;	 fixed	 cells	
were	 stained	 with	 anti-OGFOD1	 antibody	 and	 Alexa-488	 coupled	 secondary	 antibody,	 DNA	 was	
counterstained	with	DAPI.	
	
To	 investigate	OGFOD1	 protein	 amounts	 in	 the	 different	 cell	 cycle	 phases	 in	more	 detail,	
Hek293T	and	HeLa	cells	were	synchronized	with	a	double	thymidine	block	which	leads	to	an	
early	S	phase	block	(Figure	30	A).	After	release	from	the	second	thymidine	block,	cells	were	












Figure	 30:	 A)	 Experimental	 scheme	 for	 Hek293T/HeLa	 cell	 synchronization.	 Cells	 were	 synchronized	 by	 a	
double	 thymidine	 block	 resulting	 in	 early	 S	 phase	 block;	 B)	 Cell	 cycle	 profile	 of	 a	 asynchronized	 cell	
population,	cellular	DNA	content	allows	classification	of	cells	into	the	different	cell	cycle	phases	as	indicated,	
relative	 DNA	 content	 is	 plotted	 against	 cell	 number;	 C)	 Protein	 levels	 corresponding	 to	 each	 time	 point	
OGFOD1,	Cyclin	A2,	and	Actin	as	loading	control	obtained	from	Hek293T	cells	at	different	time	points	during	










Due	to	the	cell	cycle	 independency	of	OGFOD1	protein	 levels,	we	asked	 if	 interaction	with	













































Figure	 31:	 Interaction	 studies	 of	 OGFOD1	with	 CCNA2	 in	 HeLa	 cells	 during	 the	 cell	 cycle;	 HeLa	 cells	were	
synchronized	with	 a	double	 thymidine	block.	 Samples	were	 taken	after	 indicated	hours	 after	 release.	 Cell	






Western	 blot	 analysis	 of	 synchronized	 cells	 showed	 cell-cycle	 regulated	 expression	 of	






not	 be	 excluded	 in	 this	 assay.	With	 OGOFD1	 being	 precipitated,	 weak	 CCNA2	 interaction	
















































































a	double	 thymidine	block.	Between	 the	 first	 and	 second	block,	 cells	were	 transfected	with	 indicated	GFP-
tagged	 proteins.	 Samples	 were	 harvested	 after	 indicated	 hours	 after	 release.	 Cell	 cycle	 profiles	 were	
obtained	 by	 flow	 cytometry	 after	 NUCLEAR-ID®	 Red	 DNA	 stain	 (ENZO	 life	 science,	 ENZ-52406)	 staining	 of	
DNA.	In	A)	untransfected	cells	B)-D)	overexpression	of	GFP-tagged	proteins	as	indicated	
In	 initial	experiments,	Hek293T	cells	were	transfected	between	first	and	second	thymidine	












32	 B),	 already	 at	 4	 h	 post-release	 the	 main	 peak	 of	 OGFOD1-GFP	 overexpressing	 cells	 is	
oriented	more	 to	 the	2N	content	 (Figure	32	C).	Also	 the	cells	at	6	and	7	h	 seemed	not	 to	
proceed	to	4N	and	mitosis,	but	might	remain	in	the	intermediate	state	of	S	phase.	However,	







Specimen 0h O1axa.fcs GFP-positive 48525
Specimen 2h O1axa.fcs GFP-positive 31005
Specimen 4h o1axa.fcs GFP-positive 50568
Specimen 6h o1 axa.fcs GFP-positive 27852
Specimen 7h o1axa.fcs GFP-positive 53982
Specimen 9h o1axa.fcs GFP-positive 50248
Sample Name Subset NameCount
Specimen 0h.fcs GFP-negative 2895
Specimen 2h.fcs GFP-negative 2580
Specimen 4h.fcs GFP-negative 13352
Specimen 6h.fcs GFP-negative 12851
Specimen 7h.fcs GFP-negative 22288
Specimen 9h.fcs GFP-negative 15874
Sample Name Subset Name



































Specimen 0h nls.fcs GFP-positive 27857
Specimen 2h nls.fcs GFP-positive 15670
Specimen 4h nls.fcs GFP-positive 19868
Specimen 6h nls.fcs GFP-positive 35312
Specimen 7h nls.fcs GFP-positive 37452
Specimen 9h nls.fcs GFP-positive 70167
Sample Name Subset Name Count
Specimen 0h O1.fcs GFP-positive 41771
Specimen 2h o1.fcs GFP-positive 29504
Specimen 4h o1.fcs GFP-positive 41997
Specimen 6h o1.fcs GFP-positive 41716
Specimen 7h o1.fcs GFP-positive 54308
Specimen 9h o1.fcs GFP-positive 62084










Overexpression	 of	 OGFOD1	 and	 AxA	mutant	was	 also	 tested	 in	 another	 setting.	 Hek293T	
cells	 were	 co-transfected	 with	 Flag-CCNA2	 and	 either	 OGFOD1,	 or	 OGFOD1	 AxA	 (H155A,	





Figure	 33:	 Selection	 of	 proteins	 with	 highest	 enrichment	 identified	 in	 Flag-CCNA2	 IP	 with	 additional	
overexpression	 of	 OGFOD1	 wild	 type	 (WT),	 OGOFD1	 H155A,	 D157A	 (MUT),	 and	 OGFOD2	 Isoform	 1	
(OGFOD2I1,	„control“)	using	LC-MS/MS;	A)	Anti	Flag-IP	was	performed	with	ANTI-FLAG®	M1	Agarose	Affinity	
Gel	 with	 Hek293T	 cell	 lysates	 overexpressing	 indicated	 proteins	 and	 analyzed	 by	 LC-MS/MS;	 B)	 Proteins	
identified	to	be	highly	enriched	in	the	Flag-CCNA2-IP	versus	the	control	sample.	
Comparison	of	 CCNA2	binding	proteins	 revealed	 several	 proteins	 like	HNRNPH2	or	DDX46	
which	were	enriched	 in	Flag-CCNA2	 IP	 samples	when	OGFOD1	wild	 type	 (WT)	or	OGFOD1	
MUT	(OGOFD1	AxA)	were	overexpressed	(Figure	33	B).	
	
We	 also	 performed	 anti-CCNA2	 IP	 of	 endogenous	 CCNA2	 and	 characterized	 the	 binding	
proteins	 with	 LC-MS/MS.	 Many	 known	 interactors	 of	 CCNA2	 were	 identified	 like	 cyclin	
dependent	kinases	(CDKs)	1	and	2	or	SKP2,	also	SCAPER121,122	was	highly	enriched	in	CCNA2	
IP	versus	the	control	(see	Appendix	6.1.1,	Figure	70).	LC-MS/MS	results	of	the	Flag-CCNA2	IP	
(Figure	 33)	 were	 filtered	 for	 specific	 interaction	 partners	 of	 CCNA2,	 that	 were	 identified	
before	in	mass	spectrometry	results	from	endogenous	immunoprecipitated	CCNA2.		
Using	 these	 parameters,	 RPA2	 and	 RPA1	were	 identified	 as	 proteins	 which	 showed	most	
increased	 binding	 to	 CCNA2,	when	OGFOD1	 or	 OGFOD1	 AxA	mutant	were	 overexpressed	
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of	 CCNA2	 identified	 by	 endogenous	 CCNA2-IP	 before;	 B)	 Proteins	 identified	 to	 be	 highly	 enriched	 or	
decreased	in	the	Flag-CCNA2-IP	versus	the	control	sample	
	
To	exclude,	 that	changes	 in	CCNA2	binding	where	due	to	OGFOD1	 induced	changes	of	 the	
subcellular	localization	of	CCNA2,	immunofluorescent	stainings	with	overexpressed	OGFOD1	
















compared to endogenous 
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a	 proline	 residue118.	 eEF2K	 phosphorylates	 eukaryotic	 elongation	 factor	 2	 (eEF2),	 this	
modification	 inhibits	 eEF2s	 ability	 to	 interact	 with	 the	 ribosome	 and	 thereby	 impairs	
translation	 elongation.	 Proline	 98	 hydroxylation	 of	 eEF2K	 restrained	 its	 activity	 and	might	
regulate	translation	via	eEF2118.		






indicated;	 OGFOD1-GFP	 and	 Flag-tagged	 eEF2K	 were	 detected	 with	 indicated	 antibodies	 in	 subsequent	
Western	blotting.	I=Input,	F=	Flowthrough,	B=	Beads	fraction.	





















































cells	 and	 subjected	 to	GFP-IP	 (Figure	 36).	As	 control,	NLS-GFP	was	 coexpressed	with	 Flag-





Figure	 37:	 Fluorescent	 two-hybrid	 (F2H)	 assay	 to	 study	 interactions	 of	 OGFOD1	 and	 eEF2K;	 different	
combinations	of	GFP-tagged	and	Flag-tagged	eEF2K	were	co-transfected:	A-A’’	GFP-OGFOD1	and	Flag-eEF2K,	
B-B’’	 OGFOD1-GFP	 and	 Flag-eEF2K,	 C-C’’	 GFP-NLS	 and	 Flag-eEF2K,	 Nuclei	 were	 counterstained	 with	 DAPI,	
Flag-tagged	 eEF2K	 was	 stained	 with	 anti-Flag	 antibody	 and	 corresponding	 Alexa594	 coupled	 secondary	
antibody,	arrows	indicate	location	of	the	GFP	spot	also	in	the	other	channels.	
The	 F2H	 assay	 did	 not	 confirm	 results	 from	 IP	 experiments.	 Coexpression	 of	 GFP-tagged	
OGFOD1	and	Flag-eEF2K	did	not	result	in	a	recruitment	of	Flag-tagged	eEF2K	by	OGFOD1	to	































In	 order	 to	 identify	 a	 domain	 in	OGFOD1	 responsible	 for	 SG	 recruitment,	 GFP	 tagged	 full	




However,	 cells	 expressing	 GFP-tagged	 OGFOD1	 showed	 TIA-1	 stress	 granules,	 but	 no	





Figure	 39:	OGFOD1,	HA-OGFOD1,	 and	 TIA-1	 reorganization	 in	 arsenite	 treated	HeLa	 cells	 over	 time,	 A-B’’’	
HeLa	cella	were	treated	with	1	mM	arsenite	for	1	h,	then	fixed	and	co-stained	with	anti-OGFOD1	and	anti-
TIA-1	 antibodies	 and	 Alexa-488	 and	 Alexa-594	 coupled	 secondary	 antibodies;	 C-D’’’	 HeLa	 cells	 were	
transfected	with	HA-OGFOD1,	allowed	to	recover	from	transfection	for	48	h	and	treated	with	1	mM	arsenite	





to	 the	 stress	granule	marker	TIA-1	 (Figure	39	D’’).	 Endogenous	OGFOD1	 translocates	after	









A-C’’’	HeLa	 cells	were	 transfected	with	 internally	HA-tagged	OGFOD1	 (intHA-OGFOD1),	 allowed	 to	 recover	
from	transfection	 for	48	h	and	 in	B-C’’’	 additinally	 treated	with	1	mM	arsenite	 for	1	h,	 then	 fixed	and	co-
stained	 with	 anti-OGFOD1	 and	 anti-TIA-1	 antibodies	 and	 Alexa-488	 and	 Alexa-594	 coupled	 secondary	
antibodies;	DNA	was	counterstained	with	DAPI.	
	
However,	 the	 internal	 HA-tag	 was	 not	 recognized	 by	 anti-HA	 antibody	 in	 IF	 experiments	




Cells	 with	 higher	 level	 of	 OGFOD1	 staining	 were	 mostly	 in	 apoptosis,	 as	 the	 nuclei	 were	
brighter	 and	 deformed	 (Figure	 40	 B).	 Endogenous	 OGFOD1	 identified	 by	 lower	 protein	
expression	 levels	 compared	 to	 overexpressing	 cells,	 localized	 upon	 arsenite	 treatment	 to	
TIA-1	positive	stress	granules	(Figure	40	C’’).	The	internal	HA	tagged	OGFOD1	could	not	be	
observed	 in	 stress	 granules,	 but	 also	no	 cells	with	normal	nuclear	morphology	 and	higher	
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Knockout	 cell	 lines	 in	 Hek293	 cells	 were	 generated	 with	 the	 CRISPR	 (Clustered	 Regularly	
Interspaced	Short	Palindromic	Repeats)/Cas9	system121.	With	this	method,	sequence	specific	
double	stranded	DNA	breaks	(dsDNA)	can	be	 introduced	by	guideRNAs	(gRNAs)	coupled	to	
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seemed	 to	 be	 heterozygous	 for	 OGFOD1	 gene	modification.	 PCR	 analysis	 of	 clone	 D2	 for	
OGFOD1	knockout	showed	this	heterozygous	genomic	situation,	as	we	can	see	wildtype	and	




gene	was	 edited	 resulting	 in	 a	 premature	 stop	 codon	 at	 amino	 acid	 52	 (Figure	 42	D),	 the	




Figure	 42:	 Validation	 of	 OGFOD1	 heterozygous	 knockout	 strain	 D2;	 A)	 Screening	 of	 genotypes	 by	
amplification	of	the	genomic	locus	of	OGFOD1	for	clone	D2	and	Hek293	untreated	cells	as	control	(WT);	B)	
Sequencing	of	PCR	amplified	targeted	genomic	DNA	locus,	underlined	gRNA	targeting	site,	scissors	indicate	
cutting	 site,	 in	 magenta	 the	 PAM	 sequence;	 C)	 Western	 blot	 analysis	 of	 protein	 amount,	 endogenous	
OGFOD1	and	Actin	as	loading	control	were	detected	with	indicated	antibodies;	D)	Amino	acid	alignment	of	
protein	sequence	after	genome	editing	and	wild	type	sequence.	
The	 heterozygous	 knockout	 cell	 line	 for	 OGFOD1	 (Hek293	 O1D2)	 was	 further	 analyzed	 in	
immunofluorescence	 stainings.	 Also	 IF	 experiments	 using	 antibodies	 directed	 against	
WT     >ACCCTGCACTGGCCACATACTATGGGTCC ... GTGAATGTCTGCCGGTGTGTCAATGGGAAG  
Clone3 >ACCCTGCACTGGCCACATAC--------- ... --------------------CAATGGGAAG
MinA53WT_Exon1    .. LIQRDDPALATY--YGSLFKLTDLKSLCSRGM ..
MinA53KO_Clone3   .. LIQRDDPALATYQWEEEGFK*RWQST
AA 84
C) Western blot analysis
A) Genomic PCR analysis
O1_WT      .. KKQVAEAWSRRTPFSHEVIVM... 




    WT       >TGTATTAGCTCTGCTATGTTACTTGGATGTCAAAAATACA  ...  CCCCTGCCACATTAACTCTTCCAGCTTG
    O1D2_DEL >TGTATTAGCTCTGCTATGTT--------------------  ...  ----------------------AGCTTG
    O1D2_WT  >TGTATTAGCTCTGCTA----ACTTGGATGGCAAAAAT---  ...  ---------------------CAGCTTG
   
B) Sequencing of PCRs
D) Amino acid alignment
C) Western blot analysis
A) Genomic PCR a alysis
B) Sequencing of PCRs
D) Amino acid alignment
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WT   D2
bp
WT    >CCTGCCCTTGAGGTCCAGGAAGATACGAAAG  ...  CGACCTGGGGGACGCGCTACCCGGTGGGGC
Clone3>CCTGCCCTTGA--------------------  ...  ---------GGACGCGCTACCCGGTGGGGC     
  
NO66_WT      .. LALPLRSRKIRKQLRSVVSRMAALRTQTLPSENSEESRVESTADDLGDAL...
NO66_CRISPR  .. LALPLGRATRWGGGG .. 73 RANDOM AA .. VVRGPCDGVGAAGG* 
NO66_CLONE3  .. LALPLRTRYPVGRRW .. 62 RANDOM AA .. CCAPRNT*














WT  #3   #4   #6    #7bp
NO66
C) Western blot analysis
A) Genomic PCR analysis
B) Sequencing of PCRs









A	 second	 attempt	 to	 generate	 homozygous	 knockout	 cells	 for	 OGFOD1	 starting	 with	 the	
heterozygous	 clone	 D2	 did	 not	 succeed.	 The	 second	 round	 of	 transfection	 with	 CRISPR	
plasmids	and	following	selection	with	puromycin	resulted	in	no	surviving	cells.		
In	 contrast,	 generation	 of	 knockout	 cell	 lines	 for	 NO66	 and	 MINA53	 was	 successful	 and	
























To	 adress	 OGFOD1’s	 function	 as	 ribosomal	 oxygenase,	 ribosomes	 of	 the	 cell	 line	 Hek293	
OGFOD1	 D2	were	 isolated	 and	 analyzed	with	 two	methods.	 First,	 ribosome	 profiles	 after	







2	 pmol	 of	 crude	 ribosomes	 were	 additionally	 analyzed	 by	 label-free	 LC	 MS/MS	 (in	

































































2.3.1 Interaction	 studies	 of	 MINA53/NO66	 mutants	 with	 the	 respective	
substrates	
The	human	ribosomal	oxygenases	MINA53	and	NO66	hydroxylate	histidine	 residues	 in	 the	
ribosomal	proteins	RPL27a	and	RPL8,	respectively.	Both	proteins	are	localized	in	the	nucleoli,	
even	in	the	same	nucleolar	subcompartment51,52.	Crystal	structures	also	reveal	a	remarkable	
analogy.	 The	 Fe(II)	 and	 2OG	 oxygenases	 characterizing	 JmjC	 domain,	 a	 dimerization	










Both	 MINA53	 and	 NO66	 form	 dimers	 or	 even	 oligomers	 in	 crystal	 structures6,122,123,	 this	
homo-oligomerization	was	linked	to	the	enzymatic	activity	in	in	vitro	assays6,122.	
In	order	to	corobate	those	results	in	vivo,	dimerization	in	cells	was	tested	and	confirmed	in	
the	 course	 of	 a	 bachelor	 thesis	 by	 Kevin	 Brockers53.	 MINA53	 and	 NO66	 showed	 homo-
oligomerization	 in	cells	and	also	the	proposed	dimerization	domain	 in	crystal	structure	has	
been	 confirmed	 in	 cells.	 Variants	 of	 MINA53	 and	 NO66	 lacking	 the	 dimerization	 domain	
(amino	 acids	 271-339	 for	 MINA53,	 amino	 acids	 439-511	 for	 NO66)	 showed	 no	 homo-
oligomerization.	 Based	 on	 crystal	 structure	 data,	 Kevin	 Brockers	 also	 generated	 MINA53	
Triple	 (W264A,	 F267A,	 L308A)	 and	 NO66	 Triple	 (W428A,	 F431A,	 L436A)	 mutants.	 Those	
mutants	have	been	shown	to	form	no	oligomers	in	cells53.	
	
Within	 this	 thesis,	 experiments	 have	 been	 performed	 to	 gain	 further	 insights	 into	 the	
importance	 of	 homo-oligomerization	 in	 cells.	 Therefore	 GFP-tagged	 wild	 type,	 AxA,	 and	
MINA53
NO66






























































































and	 mutants,	 and	 Flag-tagged	 RPL27a	 were	 detected	 with	 indicated	 antibodies	 in	 subsequent	 Western	
blotting;	I	=	input,	F	=	flow-through,	B	=	beads.	
	









The	 same	 experimental	 set-up	was	 used	 for	NO66	with	 its	 substrate	 RPL8.	 For	GFP-NO66	
and	Flag-RPL8,	 interaction	could	be	observed	upon	GFP-IP	of	GFP-NO66	(Figure	47	A).	Also	
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for	the	AxA	mutant,	the	 interaction	still	 took	place	(Figure	47	B).	The	triple	mutant,	that	 is	













In	 contrast	 to	OGFOD1	where	 knockout	 seemed	 to	be	 lethal	 in	Hek293	 cells	 (see	Chapter	







of	 MINA53	 for	 knockout	 clones	 1-4,	 wild	 type	 clone	 #5,	 and	 Hek293	 untreated	 cells	 as	 control	 (WT);	 B)	
Sequencing	of	PCR	amplified	targeted	genomic	DNA	locus,	underlined	gRNA	targeting	site,	scissors	indicate	







WT     >ACCCTGCACTGGCCACATACTATGGGTCC ... GTGAATGTCTGCCGGTGTGTCAATGGGAAG  
Clone3 >ACCCTGCACTGGCCACATAC--------- ... --------------------CAATGGGAAG
MinA53WT_Exon1    .. LIQRDDPALATY--YGSLFKLTDLKSLCSRGM ..
MinA53KO_Clone3   .. LIQRDDPALATYQWEEEGFK*RWQST
AA 84
C) Western blot analysis
A) Genomic PCR analysis
O1_WT      .. KKQVAEAWSRRTPFSHEVIVM... 




    WT       >TGTATTAGCTCTGCTATGTTACTTGGATGTCAAAAATACA  ...  CCCCTGCCACATTAACTCTTCCAGCTTG
    O1D2_DEL >TGTATTAGCTCTGCTATGTT--------------------  ...  ----------------------AGCTTG
    O1D2_WT  >TGTATTAGCTCTGCTA----ACTTGGATGGCAAAAAT---  ...  ---------------------CAGCTTG
   
B) Sequencing of PCRs
D) Amino acid alignment
C) Western blot analysis
A) Genomic PCR analysis
B) Sequencing of PCRs
D) Amino acid alignment
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WT   D2
bp
WT    >CCTGCCCTTGAGGTCCAGGAAGATACGAAAG  ...  CGACCTGGGGGACGCGCTACCCGGTGGGGC
Clone3>CCTGCCCTTGA--------------------  ...  ---------GGACGCGCTACCCGGTGGGGC     
  
NO66_WT      .. LALPLRSRKIRKQLRSVVSRMAALRTQTLPSENSEESRVESTADDLGDAL...
NO66_CRISPR  .. LALPLGRATRWGGGG .. 73 RANDOM AA .. VVRGPCDGVGAAGG* 
NO66_CLONE3  .. LALPLRTRYPVGRRW .. 62 RANDOM AA .. CCAPRNT*














WT  #3   #4   #6    #7bp
NO66
C) Western blot analysis
A) Genomic PCR analysis








NO66	 for	 knockout	 clones	 3,	 4,	 6,	 7	 and	 Hek293	 untreated	 cells	 as	 control	 (WT);	 B)	 Sequencing	 of	 PCR	
amplified	targeted	genomic	DNA	locus,	 in	magenta	the	PAM	sequence;	C)	Western	blot	analysis	of	protein	
amount,	endogenous	NO66	and	Actin	as	loading	control	were	detected	with	indicated	antibodies;	D)	Amino	
acid	 alignment	 of	 protein	 sequence	 after	 genome	 editing,	 sequence	 of	 planned	 editing,	 and	 wild	 type	
sequence.	
2.3.2.2 Characterization	of	knockout	strains	for	MINA53	and	NO66	
To	 characterize	 the	 roles	 of	 the	 respective	 ribosomal	 oxygenases,	 knockout	 cell	 lines	 for	






MINA53	 knockout	 strains	 #3	 and	 #4	 were	 analyzed	 by	 immunofluorescence.	 Staining	 of	




WT     >ACCCTGCACTGGCCACATACTATGGGTCC ... GTGAATGTCTGCCGGTGTGTCAATGGGAAG  
Clone3 >ACCCTGCACTGGCCACATAC--------- ... --------------------CAATGGGAAG
MinA53WT_Exon1    .. LIQRDDPALATY--YGSLFKLTDLKSLCSRGM ..
MinA53KO_Clone3   .. LIQRDDPALATYQWEEEGFK*RWQST
AA 84
C) Western blot analysis
A) Genomic PCR analysis
O1_WT      .. KKQVAEAWSRRTPFSHEVIVM... 




    WT       >TGTATTAGCTCTGCTATGTTACTTGGATGTCAAAAATACA  ...  CCCCTGCCACATTAACTCTTCCAGCTTG
    O1D2_DEL >TGTATTAGCTCTGCTATGTT--------------------  ...  ----------------------AGCTTG
    O1D2_WT  >TGTATTAGCTCTGCTA----ACTTGGATGGCAAAAAT---  ...  ---------------------CAGCTTG
   
B) Sequencing of PCRs
D) Amino acid alignment
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WT    >CCTGCCCTTGAGGTCCAGGAAGATACGAAAG  ...  CGACCTGGGGGACGCGCTACCCGGTGGGGC
Clone3>CCTGCCCTTGA--------------------  ...  ---------GGACGCGCTACCCGGTGGGGC     
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WT  #3   #4   #6    #7bp
NO66
C) Western blot analysis
A) Genomic PCR analysis
B) Sequencing of PCRs















Figure	51:	MINA53	and	UBF	protein	 levels	 in	Hek293	and	Hek293	KO-MINA53	#4;	 fixed	 cells	were	 stained	
with	 anti-MINA53,	 anti-UBF,	 and	 anti-NO66	 antibodies	 and	 Alexa-488	 or	 Alexa-594	 coupled	 secondary	
antibody,	DNA	was	counterstained	with	DAPI.	
Knockout	of	MINA53	did	not	change	NO66	or	UBF	localization	in	nucleoli.	Compared	to	wild	
type	 cells,	 stainings	 of	 UBF	 (Figure	 51	 A’’)	 and	 NO66	 (Figure	 51	 C’	 and	 C’’)	 were	 also	
comparable	in	KO-MINA53#4	(Figure	51	B’’,	C’,	and	C’’).	
	
Initial	 NO66-stainings	 in	 the	 knockout	 cell	 lines	 Hek293	 KO-NO66	 #3	 and	 #4	 (Figure	 52)	
revealed	a	different	picture.	Knockout	strain	#3	was	a	complete	NO66	knockout,	as	no	NO66	
was	detected	 in	 IF	 (Figure	52,	B-B’’).	However,	 in	Hek293	KO-NO66	#4	 IF	staining	revealed	
that	around	30-40%	of	cells	still	express	NO66	(Figure	52	C-C’’),	even	though	protein	levels	



















hypoxia	 (Figure	54).	MINA53	knockout	 strain	#3	 (MinA_3)	and	MINA53	knockout	 strain	#4	
(MinA_4)	grew	slower	compared	to	wild	type	 in	normoxic	as	well	as	 in	hypoxic	conditions.	
MinA_4	 showed	 a	 significant	 slower	 growth	 in	 normoxia	 and	 hypoxia.	 MinA_3	 grew	




Figure	 54:	 Growth	 assay	 for	 MINA53	 and	 NO66	 knockout	 cell	 lines;	 growth	 was	 performed	 in	 three	
independent	 experiments,	 values	 and	 standard	 error	 bars	 represent	 the	mean	 of	 three	 replicates	 of	 one	
experiment;	knockout	 cell	 lines	MINA53#3	and	#4,	NO66#3	and	#4,	and	wild	 type	Hek293	were	 seeded	at	







Ribosomes	 of	 knockout	 cell	 lines	 Hek293	 KO-MINA53#4	 and	 Hek293	 KO-NO66#3	 were	





















































































































To	 analyze	 the	 ribosomes	 with	 regard	 to	 differences	 in	 protein	 modifications,	 2	 pmol	 of	
crude	ribosomes	were	analyzed	by	label-free	LC	MS/MS	(Ignasi	Forné,	Axel	Imhof	laboratory,	
Biomedical	Center	Munich,	LMU).	Three	biological	replicates	of	Hek293	(WT)	ribosomes,	and	









Figure	 55:	 Panther	 gene	 ontology	 (GO)	 term	 analysis	 for	 proteins	 of	 isolated	 ribosomes	 identified	 by	 LC-
MS/MS,	displayed	are	the	fold	enrichment	of	certain	GO	terms	and	P-values	of	the	enrichment 
MINA53,	 NO66,	 and	 OGFOD1	 are	 reported	 to	 modify	 certain	 amino	 acids	 in	 different	
ribosomal	 proteins.	 MINA53	 hydroxylates	 His39	 in	 RPL27a,	 NO66	 His216	 in	 RPL8	 and	
OGFOD1	 Pro62	 in	 RPS235,6.	 Having	 a	 deeper	 look	 into	 those	 proteins	 and	 corresponding	
peptides	revealed	that	those	peptides	of	interest	could	be	detected	in	LC-MS/MS	(Table	3).	
RPL27a	 peptides	were	 identified	with	 hydroxylated	 His	 (His	 OH)	 in	 all	 samples	 but	 not	 in	
MINA53-KO	replicates	 (Table	3),	here	only	unmodified	RPL27a	peptide	was	found.	Also	for	
RPL8	and	NO66	 in	the	knockout	sample,	only	unmodified	peptide	could	be	detected,	 in	all	
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Table	3:	Peptides	of	 interest	 in	 ribosome	preparations	 from	different	knockout	 cell	 lines,	 identified	by	 LC-
MS/MS	and	described	by	intensities	
With	 the	 fragmentation	 spectra,	 the	16	Dalton	mass	 shift	 corresponding	most	 likely	 to	 an	






Figure	56:	Fragmentation	assignments	 for	RPL27a	peptide	 in	different	samples;	hydroxylated	peptide	 in	A)	
Hek293	(WT)	sample	2	and	B)	Hek293	KO-NO66#3	sample	2,	unmodified	peptide	in	C)	Hek293	KO-MINA53#4	

















-	H(ox) +	H(ox) -	H/P(ox) +	H/P(ox) -	P(ox) +	P(ox)
		Experiment Intensity Intensity Intensity Intensity Intensity Intensity
		WT_1 0 771490 0 2436787 0 1655721
		WT_2 0 2958200 0 4396868 0 1470175
		WT_3 0 637970 0 5565551 0 2598005
		MINA53KO_1 1735200 0 0 3276900 0 429275
		MINA53KO_2 3081800 0 0 1768712 0 77292
		NO66KO_1 0 190520 6106797 0 0 1045812
		NO66KO_2 0 22365000 16539008 0 0 3034149
		O1D2pm_1 0 2259800 0 7609789 0 1702980
		O1D2pm_2 0 260170 0 517795 0 462882
RPL27a	peptide RPL8	peptide RPS23	peptide
Hek293 KO-MINA53#4_1 Hek293 KO-MINA53#4_2
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The	 analysis	 of	 ribosomes	 isolated	 from	 the	 different	 generated	 cell	 lines	 showed	 no	
intriguing	 differences	 in	 the	 ribosome	 profiles.	 Mass	 spectrometry	 based	 experiments	
confirmed	Hek293	KO-MINA53#4	and	Hek293	KO-NO66#3	being	knockout	cell	lines.	Also	the	
reported	substrates	could	be	identified	and	were	dependent	on	MINA53	or	NO66.	OGFOD1	








MINA53/NO66	wild	 type	protein,	 the	 iron	binding	AxA	 (MINA53	H179A,	D181A	and	NO66	
H340A,	 D342A)	 mutant	 or	 the	 Triple	 mutant	 (MINA53	 W264A,	 F267A,	 L308A	 and	 NO66	









   1       2       3      4          
50
Lane1: Hek293-MINA53-KO#4
Lane2: Hek293-MINA53-KO#4 + MinA53-WT
Lane3: Hek293-MINA53-KO#4 + MinA53-AxA
Lane4: Hek293-MINA53-KO#4 + MinA53-Triple








B Quantification of MINA53 and 






































































































































C FACS analysis of MINA53 KO#4 




58	 A)	 and	 by	 flow	 cytometry.	 The	MINA53/NO66	 variants	were	 cloned	 into	 a	 vector	 that	
encodes	 the	 CD2	 marker.	 Cloned	 insert	 and	 CD2	 marker	 sequence	 are	 separated	 by	 the	
„self-cleaving“	2A	peptide	(T2A	site)	which	causes	the	ribosome	to	skip	at	this	sequence	and	
to	 start	 translation	 again	 at	 the	 next	 C-terminal	 start	 codon125.	 In	 case	 of	 reconstitution,	





Quantification	 of	 western	 blot	 signals	 for	 MINA53	 and	 NO66	 in	 the	 different	 cell	 lines	
















Lane2: Hek293-NO66-KO#3 + NO66-WT
Lane3: Hek293-NO66-KO#3 + NO66-AxA
Lane4: Hek293-NO66-KO#3 + NO66-Triple
   1       2       3      4          





B Quantification of NO66 and 




































































































































C FACS analysis of NO66 KO#3 





1.1*103	 cells	 were	 seeded	 in	 six	 biological	 replicates	 and	 measured	 for	 5	 days	 for	 cell	 viability	 using	






type)	 cells,	 the	MINA53	 overexpressing	 cell	 line	 (MINA53	WT	 OE)	 showed	 an	 even	more	
reduced	growth	(Figure	59	A).	In	hypoxia,	those	effects	could	not	be	detected	in	a	significant	
range	 (Figure	 59	 B).	 Reconstitution	 of	 the	 knockout	 cell	 line	 with	 wild	 type	 MINA53	
(MINA53-KO#4-WT),	 iron	 binding	 defective	 mutant	 MINA53-AxA	 (MINA53-KO#4-AxA)	 or	
dimerization	 triple	 mutant	 ((MINA53-KO#4-Triple)	 resulted	 in	 no	 major	 differences	
compared	to	the	knockout	or	wild	type	in	normoxic	or	hypoxic	conditions	(Figure	59	A,	B).	
	
Growth	 of	 NO66	 cell	 lines	 showed	 a	 quite	 similar	 picture	 as	 MINA53	 cell	 lines.	
Overexpression	of	NO66	 in	normoxic	conditions	seemed	to	slow	down	growth	significantly	
(Figure	59,	C,	NO66	WT	OE)	 (Figure	59	C).	NO66	knockout	cells	 (NO66-KO#3)	grew	slightly	
better	 than	wild	 type.	 Reconstitution	 of	 the	 knockout	 with	 NO66	wild	 type	 (NO66-KO#3-
WT),	 AxA	 cell	 line	 (NO66-KO#3-AxA),	 and	 triple	mutant	 (NO66-KO#3-Triple)	 resulted	 in	 no	
significant	differences	compared	to	the	knockout	or	wild	type	in	normoxic	conditions	(Figure	




















































































































































Figure	 60:	 Clustal	 omega	 alignment	 of	 MINA53	 protein	 sequences	 from	 H.sapiens	 (Uniprot	 :	 Q8IUF8),	














H.sapiens       MPKKAKPTG----SGK------------E-EGPAPCKQMK-LEA-AGGPSALNFDSPSSLFESLISPIKTETFFKEFWEQ
M.musculus      MPKKVQPTG----DEN------------E-EASVPCKRVK-EEL-PETLSVLNFDSPSSFFESLISPIKVETFFKEFWEQ
D.rerio         MPKISRRAARRSGQEERLQRVSSASSPATQRSGSPQEIEQ-EERLQRVSTLSSSGSPQEFFQSLIRPLDLQEFFQRFWER
X.laevis        MPRRGRKEQ----EPE----------------HSEPKLAK-RDE-ADSKSPLDFSTPEKLFESLISPVTSDAFFRDYWET
H.vulgaris      MVK---RKGS-------------SSDDVA--KNVTKKVKKVSDVNEQKESKLNYTSCESVMSSLLQPISVKTFFEEFWEK
                * :                                 :  :  :      :  .  : ... :.**: *:  . **. :** 
H.sapiens       KPLLIQRDDPALATYYGSLFKLTDLKSL-CSRGMYYGRDVNVCRCVNGKKKVLNKDGKAHFLQLRKDFDQKRATIQFHQP
M.musculus      KPLLIQRDDPVLAKYYQSLFSLSDLKRL-CKKGVYYGRDVNVCRSISGKKKVLNKDGRAHFLQLRKDFDQKRATIQFHQP
D.rerio         QPLVLHRSDAALAGYYGSLFPLSGLRRL-CARGLQYGTDINTCRCVRGQKRLLNRAGAVDFCLLERDFLEKKATIQFHQP
X.laevis        KVLLLQGRDPAFTDYFQTLFRLSDLKHI-AGGGIYYERDVNVFKCRDGKKIALPRHGKATYLHLLKDFGSGKATIQFHQP
H.vulgaris      KPLYIKREN---SGYYGDLFSLSSMKEILAAHELEFETDVNVCRYVDNEKELLNEDGCLTVDKFDKLMNDKHATFQLHQP
               : * ::  :   : *:  ** *:.:: : .   : :  *: *. :   .:*  * . *      : : : . :**:*:***
H.sapiens       QRFKDELWRIQEKLECYFGSLVGSNVYITPAGSQGLPPHYDDVEVFILQLEGEKHWRLYHPTVPLAREYSVE-AEERIGR
M.musculus      QRYKDELWRIQEKLECYFGSLVGSNVYMTPAGSQGLPPHYDDVEVFILQLEGTKHWRLYSPTVPLAHEYSVE-SEDRIGT
D.rerio         QRFQDELWRIQERLECFFGCLVGSNVYITPAGAQGLPPHYDDVEVLILQLEGQKHWRLYEPTVPLAREYSLE-PEGRIGA
X.laevis        QRFNDALWHIMEKLECFFGALVGSNVYITPQDSQGLPAHYDDVEVFILQLEGEKRWRLYNPVVPLARDYSVV-PEDQIGS
H.vulgaris      QRYGTVLWQLMEKMETYFGCLVGSNVYITPKESQGLAPHCDDVEVFILQLEGTKHWKLYKPMVELSRDYTQDLSQDSIGE
                **:   **:: *::* :**.*******:**  :***  * *****:****** *:*:** * * *:::*:    :  ** 
                    
H.sapiens       PVHEFMLKPGDLLYFPRGTIHQADTPAGLAHSTHVTISTYQN---------------------------------NSWGD
M.musculus      PTHDFLLKPGDLLYFPRGTIHQAETPSGLAYSIHLTISTYQN---------------------------------NSWGD
D.rerio         PTHDFILQAGDLLYFPRGTIHQADTPAGAGHSTHLTLSTYQNMCVCAVHNVTHTHTHTLQNVLVLHSFIVCVRACRSWGD
X.laevis        PTHDFVLKPGDLLYFPRGVIHQAQALPGSSHSTHVTISTYQN---------------------------------NSWSD
H.vulgaris      PIMELTLEPGDLLYFPRGTIHQARS-VGESYSTHITLSTYQN---------------------------------NTLGD
                *  :: *: *********.**** :  * .:* *:*:*****                                 .: .*
H.sapiens       FLLDTISGLVFDTAKEDVELRTGIPRQLLLQVESTTVATRRL------------------S----GFLRTLADRLEGT-K
M.musculus      CLLDSISGFVFDIAKEDVALRSGMPRRMLLNVETPADVTRKL------------------S----GFLRTLADQLEGR-E
D.rerio         LLLDLMPGCVFDRMKTDCELRTGLPRGLLTTPSISPAVSHQL------------------S----VFLQRLADVVDHQGQ
X.laevis        YLQDLLPGILFDAAKANIDLRRGIPRQQILSLDTPGVI-QQI------------------S----SLLNTVAKGLESH-R
H.vulgaris      FMSIAVSQAIESALENDVNFRRGLPINYLSYLGTAKNFSKYFDEDGKESKLSSNENNEKVKKFKDSVKKHLSKLIDHIDV
                 :   :   : .  : :  :* *:*   :          : :                  .     . . ::. ::    
H.sapiens       ELLSSDMKKDFIMHRLPPYSAGDGAELSTPGGKLPRLDSVVRLQFKDHIVLTVLPD------------------------
M.musculus      ELLSSDMKKDFVKHRLPPFFEGNGTETMDPGKQLPRLDNIIRLQFKDHIVLTVGPD------------------------
D.rerio         TLRSSSMRRDFISHRLPPFVQDPQ--LLQPVGGAPALQDTVSLRFKDHLLLTVEPS------------------------
X.laevis        HIRSFEMLRDFMASRLPPFLDNKE--PGQTSGMPPKLNSTVQLLYRDYSFFTVDHV------------------------
H.vulgaris      NTAADMMSYDFMASRLPPFGHVVKEEQLN-EFKSPTLDSKIKLRYPEHVRPVYYDQEETDEADNTVGDDDSEDEEEETVK
                   :  *  **:  ****:               * *:. : * : ::   .                            
H.sapiens       ----------------------------------------QDQSDEAQEKMVYIYHSLKNSRETHMMGN------E-EET
M.musculus      ----------------------------------------KNPFDEAQQKVVYIYHSLKNVRQMHMIGE------E-EES
D.rerio         ----------------------------------------PDHTDEATELLVYVLHSLRNRRDTHMMMGASDEDEDDEES
X.laevis        ----------------------------------------AEESNAAAEQVVYVYHSLKNTRETHMMAM------QEEDR
H.vulgaris      KDEDEKNEEKDEKSPKSNKKSSDKKDTSMEGNEDEEDEDDDDASVHDDEPCIKIVHSLNNNRETHMSGH-------DLSR
                                                         :      :  : : ***.* *: **            . 
H.sapiens       EFHGLRFPLSHLDALKQIWNS-PAISVKDLKLTTDEEKESLVLSLWTECLIQVV-------
M.musculus      EIFGLRFPLSHVDALKQIWCG-SPIRVKDLKLDTDEEKENLALSLWSESLIQVL-------
D.rerio         QVGGLRFPLSHLEALQQLLVS-DRVPVEDLQLQQ-EDKLNLLLALWSEGLLRVTGALENHH
X.laevis        PVTGLRFPLPYANALKRIWES-ESVSVGKLPLDRDEDKENLALSLWTEGLLAIVP------
H.vulgaris      DVFSLKLPIHFAQAITSVMNSNDFICVRDLPLDDDEDKLQLATSLYSDDLIEIK-------






































To	 investigate	 the	 evolution	 of	MinA53	 and	 NO66,	multiple	 protein	 sequence	 alignments	










Database	 searches	 in	 the	 basal	 pre-bilaterian	 cnidarian	 Hydra	 vulgaris	 genome126,127	





as	 well	 as	 the	 2OG	 coordinating	 amino	 acid	 were	 conserved	 for	 both	 hvMINA53	 and	
hvNO66.	However,	whereas	NO66	protein	sequence	is	quite	conserved,	several	amino	acid	








To	 examine	 conservation	 of	 both	 proteins,	 subcellular	 localization	 of	 HvMINA53	 and	
HvNO66	was	 analyzed.	 Expression	 of	 GFP-tagged	 proteins	 in	Hydra	 animals	 was	 analyzed	
upon	 transfection	 with	 a	 particle	 gun128.	 Confocal	 imaging	 of	 ectopically	 expressed	 GFP-




Figure	62:	Expression	of	Hydra	vulgaris	 (hv)	GFP-tagged	NO66	 in	Hydra	animals;	A-C’’’	 shows	hvNO66-GFP	
positive	cells	in	fixed	Hydra	vulgaris	animals,	DNA	was	counterstained	with	DAPI.	






NO66	 is	 a	 so-called	 single	 exon	 gene	 (SEG),	 lacking	 introns.	 To	 investigate	 evolution	 of	
MINA53	and	NO66	genes	and	transcripts,	phylogenetic	studies	were	conducted.	
	









contrast	 the	 human	 NO66	 (RIOX1)	 gene	 encodes	 one	 transcript	 RIOX1-003	
(ENST00000304061.7)	and	is	an	intronless	gene,	spanning	2428	bp	with	5’-	and	3’-UTRs	on	
chromosome	14.	






To	gain	further	 insights	 into	the	evolution	of	MINA53	and	NO66	genes,	more	species	 from	
the	animal	kingdom	were	included.	Amino	acid	sequences	of	MINA53	and	NO66	orthologues	
were	 identified	 in	 the	 Ensembl	 and	 EnsemblMetazoa	 genomic	 resources	 using	 the	human	
MINA53	 and	 NO66	 protein	 reference	 sequences	 in	 Protein	 BLAST	 (blastp)	 search	 (in	
collaboration	with	Andreas	Lengeling,	The	Roslin	Institute,	University	of	Edinburgh).		
In	Trichoplax	adhaerens	as	very	basic	metazoan	organism,	same	JmjC	protein	sequence	was	
found	 using	 MINA53	 or	 NO66	 sequences.	 This	 sequence	 consists	 -	 probably	 due	 to	 low	
quality	 of	 the	 published	 genome	 -	 of	 only	 the	 JmjC	 domain,	 lacking	 C-	 and	 N-termini.	
Therefore	 the	sequence	could	not	be	cleary	classified	 for	MINA53	or	NO66.	However,	 this	
sequence	was	used	and	acts	as	outgroup	to	root	the	phylogenetic	tree	(Figure	64). 
Comprehensive	 searches	 for	 MINA53	 and	 NO66	 sequence	 revealed	 for	 some	 of	 those	
species	 no	 MINA53	 (Figure	 64,	 in	 gray	 boxes).	 Model	 organisms	 Caenorhabditis	 elegans	
(C.elegans)	 and	Drosophila	melanogaster	 (D.melanogaster)	 only	 encode	NO66	 (Figure	 63),	
the	same	is	true	for	additional	 invertebrate	species	from	arthropoda,	mullosca,	nematoda,	
and	 annelida.	 Whereas	 Clonorchis	 sinensis	 and	 the	 two	 organisms	 of	 the	 Caenorhabditis	
genus	 have	 only	 NO66,	 two	 other	 organisms	 of	 the	 platyhelminthes	 phylum	 Ciona	
intestinales	and	Ciona	savingyi	contain	MINA53	and	NO66.	The	fresh-water	polyp	Hydra	as	
ClassPhylum NO66 MINA53
Homo sapiens (hs) Chordata Mammalia + +
Mus musculus (mm) (mouse) Chordata Mammalia + +
Gallus gallus (gg) (chicken) Chordata Aves + +
Danio rerio (dr) ( ) Chordata Actinopterygii + +
Rattus norvegicus (rn) (brown rat) Chordata Mammalia + +
Biomphalaria glabrata (bg) (freshwater snail) Mollusca Gastropoda + -
Strongylocentrotus purpuratus (sp) (purple sea urchin) Echinodermata Echinoidea + +
Xenopus laevis (xl) (african clawed frog) Chordata Amphibia + +
Monodelphis domestica (md) (gray short-tailed opposum) Chordata Mammalia + +
Tribolium castaneum (tc) ( ) Arthropoda Insecta + -
Latimeria chalumnae (lc) (west indian ocean coelacanth) Chordata Sarcopterygii + +
Capitella teleta (ct) Annelida Polychaeta + -
Clonorchis sinensis (cs) ( ) Platyhelminthes Trematoda + -
Ciona intestinalis (ci) (sea squirt) Chordata Tunicata + +
Drosophila melanogaster (dm) ( ) Arthropoda Insecta + -
Caenorhabditis elegans (ce) Nematoda Chromadorea + -













Figure	 64:	 Phylogenetic	 tree	 for	 MINA53	 and	 NO66	 JmjC	 domains	 in	 different	 organisms;	 maximum	
likelihood	tree	was	generated	using	ClustalW-MAFFT-Alignment,	ML-IQTree	by	Evi	Lengeling-Wollscheid	(The	
Roslin	Institute,	University	of	Edinburgh),	support	values	are	written	on	the	branches	and	are	reliable	from	
80%	 for	 the	 first	 and	 95%	of	 the	 second	 value;	 highlighted	 in	 blue	MINA53	 containing	 organisms,	 in	 light	
green	single	exon	genes	in	mammalia	and	aves,	in	gray	organisms	encoding	only	NO66.	













89/98 NO66- Xenopus laevis
NO66- Latimeria chalumnae












































100/100 MINA53- Ciona intestinales
MINA53- Ciona savingyi
MINA53- Priapulus caudatus




81.9/99 NO66- Biomphalaria glabrata
NO66- Crassostrea gigas
NO66- Lottia gigantea
69.6/90 NO66- Lingula anatina
NO66- Capitella teleta



































































Homo	 sapiens,	Mus	 musculus,	 Rattus	 norvegicus,	 and	Monodephis	 domestica	 as	 well	 as	
Gallus	gallus	as	member	of	the	avian	lineage,	NO66	consists	as	single	exon	gene.	The	insecta	
have	 NO66	 encoded	 as	 a	 gene	 with	 one	 to	 six	 exons.	 Other	 clades	 like	 for	 example	 the	
mollusca	 -	 represented	 here	 by	 Biomphalaria	 glabrata,	 Crassostrea	 gigas,	 and	 Lottia	
gigantea	 -	 exhibit	 NO66	 as	multi-exon	 gene	 (more	 than	 10	 exons).	 Fish,	 amphibians	 and	
other	chordates	all	possess	NO66	genes	with	up	to	15	exons	(Latimeria	chalumnae).	
MINA53	JmjC	domains	cluster	in	one	branch	and	can	be	clearly	separated	from	NO66	(Figure	





Low	node	 support	 (e.g.	H.robusta	 +	Chordata,	S.purpuratus	 +	L.salmonis/Insecta)	 indicates	













With	 different	 assays,	 interaction	 of	 CCNA2	 and	 OGFOD1	 could	 be	 confirmed.	 The	 N-
terminal	 DSBH	 of	 OGFOD1	 was	 found	 to	 be	 crucial	 for	 binding.	 The	 N-terminal	 domain	
harbours	the	motif	for	iron	binding	and	displays	the	catalytically	active	domain.	However,	as	
also	the	iron	binding	defective	AxA	mutant	was	able	to	bind,	the	catalytic	activity	of	OGFOD1	




protein	 can	 be	 detected	 from	 S-phase	 until	 mitosis,	 where	 it	 is	 rapidly	 degraded	 in	
prometaphase109,129,130.	In	S	phase,	CCNA2	is	bound	to	cyclin	dependent	kinase	2	(CDK2)	and	
involved	 in	 initiation	and	termination	of	DNA	replication.	During	G2/M	transition	CCNA2	 is	
associated	with	CDK1	and	needed	 for	 the	activation	of	 the	other	main	cell	 cycle	 regulator	
Cyclin	B,	probably	by	regulating	its	translocation	to	the	nucleus131,132.	 In	prometaphase	the	
sudden	degradation	of	CCNA2	 is	crucial	 for	 the	stabilization	of	kinetochore-microtubuli	 for	
the	 correct	 chromosome	 segregation133,	 ectopical	 overexpression	 can	 even	 lead	 to	
chromosomal	 double	 strand	 breaks134.	 Missregulated	 CCNA2	 causes	 major	 defects	 in	 cell	
cycle	progression133-136.	
The	exact	 functions	of	CCNA2	and	 the	 regulation	by	and	 throughout	 the	cell	 cycle	are	still	
ongoing	 research.	 Mechanisms	 regulating	 CCNA2	 were	 identified,	 like	 post-translational	
modifications	of	CCNA2.	Acetylations	of	CCNA2	affect	its	stability,	as	acetylated	CCNA2	gets	
ubiquitinylated	 by	 the	 anaphase-promoting	 complex	 (APC/C)	 and	 subsequently	
degraded137,138.	
In	 mass	 spectromtry	 (MS),	 several	 prolines	 in	 CCNA2	 with	 potential	 hydroxylation	 were	
identified.	 However,	 in	 three	 different	 experiments	 with	 recombinant,	 endogenous,	 and	






High	 conservation	 scores	 of	 P114	 in	 peptide	 2	 (Figure	 65	D)	 and	 P137	 in	 peptide	 3	made	
them	 good	 candidates	 for	 hydroxylation	 by	 OGFOD1	 which	 might	 even	 be	 conserved	
through	 evolution.	 Due	 to	 high	 conservation,	 P402	 would	 also	 be	 interesting	 for	 further	
analysis.		
	
Attempts	 to	 identify	 hydroxylation	 of	 those	 peptides	 by	 OGFOD1	 were	 performed	 by	
cooperation	partner	Cyrille	Thinnes	(C.	Schofield	laboratory,	Chemistry	Research	Laboratory,	







Figure	 65:	 Schematic	 overview	 of	 domains	 of	 CCNA2;	 A)	 coverage	 of	 CCNA2,	 dashed	 boxes	 indicate	 not	
covered	sequences;	B)	identified	potential	hydroxy	prolines	by	LC-MS/MS;	C)	selected	peptides	being	tested	
using	 petide	 hydroxylation	 assay	 based	 on	 MALDI-TOF,	 D)	 conservation	 of	 potential	 hydroxy	 prolines;	
alignments	were	generated	with	ClustalOmega,	conservation	graphes	by	JalView.	
Different	peptide	lengths	or	additional	protein	domains	of	CCNA2	might	be	needed	for	this	
in	 vitro	 approach.	 Limitations	 of	 this	 assay	 were	 already	 reported	 in	 2009139.	 Lysine	
hydroxylation	 in	 U2AF65	 by	 JMJD6	 could	 be	 detected	 with	 LC-MS/MS,	 but	 testing	 the	
corresponding	peptides	with	MALDI-TOF	showed	no	enzyme	activity	of	JMJD6	towards	the	
distinct	 lysines139.	 Therefore,	 in	 addition	 to	 the	 local	 hydroxylation	 site,	 other	 domains	 in	
CCNA2	 may	 be	 important	 for	 the	 binding	 and	 the	 catalytic	 activity	 of	 OGFOD1.	 Further,	
structural	factors	supporting	the	interaction	might	be	needed.	Using	full	length	CCNA2	from	
cell	 extracts	 in	 the	 in	 vivo	 CCNA2	 IPs	 analyzed	by	 LC-MS/MS,	 instead	of	pure	peptide	and	
recombinant	OGFOD1	could	supply	the	reaction	with	potential	helping	factors.	
To	define	CCNA2	as	substrate	of	OGFOD1	and	identify	hydroxylated	prolines,	other	methods	





OGFOD1	 expression	 did	 not	 change	 throughout	 the	 cell	 cycle,	 also	 the	 interaction	 with	
CCNA2	showed	no	cell	 cycle	dependency.	Direct	binding	of	OGFOD1	to	CCNA2,	which	was	
not	 in	 complex	 with	 CDK2,	 could	 point	 towards	 a	 CDK-independent	 function	 of	 CCNA2	
beyond	 the	 cell	 cycle.	 A	 recent	 report	 assigned	 CCNA2	 a	 CDK-independent	 role	 as	 RNA	
binding	protein	 specifically	binding	Mre11	mRNA	and	 thereby	promoting	 its	 translation140.	
More	 experiments	 concerning	 the	 nature	 of	 CCNA2-OGFOD1	 with	 regards	 to	 potential	
additional	interaction	factors	or	to	cell	cycle	timing	should	be	conducted.	
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damage141,142.	 Additionally,	 the	 complex	 binds	 proteins	 involved	 in	 DNA	 replication,	 DNA	
repair,	 and	 recombination143.	 In	 1996,	 the	 interaction	 of	 CCNA2	 and	 RPA2	 and	 RPA2	




but	 also	 RPA1	 and	 RPA2	 specifically	 when	 compared	 with	 control	 IP	 experiment.	 In	 an	
overexpression	system	with	Flag-CCNA2	and	untagged	OGFOD1	and	OGFOD1	AxA,	RPA2	was	
highly	enriched	 in	 the	Flag-CCNA2	 IP	 sample	 in	 comparison	 to	a	 control.	 This	would	 imply	
that	 enzymatic	 activity	 of	 OGFOD1	 is	 not	 involved	 in	 the	 regulation	 of	 the	 CCNA2	
interactome.	 Initial	experiments	determining	the	progression	of	synchronized	cells	through	
the	 cell	 cycle	 revealed	 some	 delay	 for	 GFP-OGFOD1	 expressing	 cells.	 Cell	 overexpressing	
NLS-GFP	 proceeded	 with	 no	 observable	 time	 lag,	 indicating	 an	 effect	 of	 OGOFD1	
overexpression	on	the	cell	cycle.		
	
In	a	 recent	 report,	a	 role	of	OGFOD1	 in	cell	proliferation	was	shown	 in	breast	cancer	cells	
and	chronic	 lymphocytic	 leukemia,	where	OGFOD1	displayed	a	high	expression91,92.	On	the	
other	 hand,	 knockdown	 in	 breast	 cancer	 cells	 led	 to	 the	 accumulation	 of	 cells	 in	G1-	 and	
G2/M	phase.	 Following	 this,	 the	 authors	 assigned	OGFOD1	 a	 role	 in	 cell	 proliferation	 and	
tumorigenesis	 and	 propose	 a	 translation-independent	 role	 for	 OGFOD1	 in	 cell	 cycle	






Recently,	 proline	 98	 of	 eukaryotic	 elongation	 factor-2	 kinase	 (eEF2K)	 was	 found	 to	 be	
hydroxylated.	This	post-translational	modification	(PTM)	of	eEF2K	restrained	its	activity	and	
might	in	turn	regulate	translation	via	eukaryotic	elongation	factor	2	(eEF2)118.	As	not	many	




Translation	 is	 regulated	 and	 repressed	 during	 distinct	 phases	 of	 the	 cell	 cycle	 and	 during	
stress119,147.	eEF2K	seems	to	provide	one	mechanisms	to	stall	translation	by	phosphorylating	
eEF2.	This	 inhibiting	phosphorylation	of	eEF2	threonin	56	 (T56)	prevents	 its	binding	to	 the	
ribosome	 and	 thereby	 impairs	 translation	 elongation148.	 EEF2K	 is	 regulated	 by	 different	
pathways	like	mTOR	signaling,	nutrient	starvation,	or	oxidative	stress	via	phosphorylation	by	
the	 AMP	 kinase149.	 Recently,	 a	 serine	 phosphorylation	 (S595)	 of	 eEF2	 carried	 out	 by	 the	
CCNA2-CDK2	complex	was	 identified	and	contributes	to	eEF2’s	regulation149.	This	cell	cycle	
dependent	phosphorylation	seems	to	 facilitate	 the	 following	 inhibitory	phosphorylation	by	







The	 CCNA2-CDK2	 dependent	 modificiation	 might	 be	 one	 mechanism	 to	 couple	 cell	 cycle	
progression	 with	 translation149.	 This	 cell	 cycle	 regulated	 translation	 inhibition	 might	 be	
mediated	 by	 OGFOD1-catalyzed	 eEF2K	 hydroxylation.	With	 the	 F2H	 assay	 this	 interaction	
could	not	be	confirmed.	In	this	experiment,	Flag-tagged	eEF2K	was	used.	This	tag	might	not	
be	 ideal	 for	 this	 assay,	 therefore,	 the	 experimental	 set-up	 could	 be	 further	 adjusted	 to	






To	unravel	 the	 function	of	OGFOD1	 in	SGs,	 first	 the	 formation	of	SGs	was	monitored	over	
time.	SGs	could	be	detected	by	TIA-1	recruitment	15	min	after	stress	induction.	Endogenous	
OGFOD1	was	recruited	 to	SGs	after	30	min.	Overexpressed	OGFOD1	 independently	of	 size	
and	location	of	the	tag	was	not	recruited	to	stress	granules,	even	though	TIA-1	role	 in	SGs	




already	 reported5,89.	 Interacting	 proteins	 comprised	 some	 stress	 granule	 proteins,	 the	
eIF2alpha	 kinase	 heme-regualted	 inhibitor	 (HRI),	 and	 eIF2alpha	 itself.	 Overexpression	 of	
OGFOD1	 resulted	 in	decreased	polysome	 levels	and	 increased	amounts	of	phosphorylated	











































Generation	 of	 OGFOD1	 knockout	 cell	 lines	 in	 Hek293	 cells	 was	 not	 possible,	 only	 one	
heterozygous	 knockout	 clone	 could	 be	 generated.	 In	 contrast,	 generation	 of	MINA53	 and	
NO66	knockouts	in	Hek293	cells	was	successful.	Judging	from	protein	levels	of	wild	type	and	
OGFOD1	 D2	 +/-	 cells,	 protein	 levels	 seemed	 even	 to	 be	 compensated	 by	 the	 remaining	
OGFOD1	 gene	 copy.	 Considering	 the	 unchanged	 protein	 amount	 and	 a	 growth	 behaviour	
comparable	 to	wild	 type	 cells,	 also	 the	 ribosomal	profile	of	 the	heterozygous	OGFOD1	D2	
cells	 did	 not	 differ	 from	 wild	 type.	 Analysis	 of	 the	 ribosomes	 by	 MS	 confirmed	 the	
compensation	 of	 OGFOD1	 protein	 levels,	 as	 the	 RPS23	 P62	 was	 only	 identified	 in	 the	
hydroxylated	status	in	OGFOD1	D2	cells.		
A	 second	 attempt	 to	 generate	 homozygous	 knockout	 cells	 starting	with	 the	 heterozygous	
clone	did	not	succeed	and	resulted	 in	no	surviving	cells.	This	 led	us	to	the	conclusion,	that	





of	 OGFOD1	 homologue	 Sud-1	 in	 D.	 melanogaster	 caused	 lethality	 in	 early	 embryonic	
development44.	In	mammalian	cell	culture	,	siRNAs	targeting	OGFOD1	caused	marked	effects	










Whereas	 knockout	 of	 OGFOD1	was	 not	 possible,	 generation	 of	 bacterial	 knockout	 strains	
lacking	 ycfD	 seemed	 to	 have	 no	 negative	 effect	 on	 bacteria.	 Earlier	 studies	 showed	 that	
overexpression	 of	 His-tagged	 ycfD	 led	 to	 tremendous	 growth	 defects,	 the	 comercially	
available	 Keio	 ycfD	 knockout	 strain	 JW1114-2103	 was	 viable4,46.	 However,	 under	 stress	
conditions	 like	 growth	 in	 minimal	 medium,	 growth	 defects	 of	 the	 knockout	 strain	 were	
observed4.	
YcfD	 knockout	 strains	 generated	 in	 this	 work	 are	 slightly	 different,	 as	 Keio	 collection	





With	 the	 strains	 generated	 in	 this	 work,	 the	 observed	 growth	 defects	 could	 not	 be	
recapitulated.	 Also	 the	 ycfD-AxA	 strain	 lacking	 catalytic	 activity	 displayed	 normal	 growth	
behaviour.	 Consistently,	 ribosome	profiles	of	 knockout	 and	AxA	mutant	 strain	obtained	 in	
this	 work	 did	 not	 display	 obvious	 effects,	 suggesting	 normal	 ribosomal	 assembly	 and	
translation	activity.	However,	 the	 reported	growth	phenotype	with	 JW1114	could	also	not	








itself	 is	 needed	 for	 formation	 of	 the	 70S	 initiation	 complex47,	 for	 the	 peptidyl	 transferase	
activity48,	 and	 to	 coordinate	 and	 stabilize	 the	 binding	 of	 A-site	 tRNAs49.	 Despite	 the	
important	functions	of	RPL16	in	the	ribosomal	context,	the	hydroxylation	by	ycfD	seems	not	
to	be	essential	in	bacteria.	
Also	 monooxygenase	 yfcM	 knockout	 in	 Salmonella	 grows	 phenotypically	 normal151.	 YfcM	
hydroxylates	 lysinylated	Lys	34	of	the	conserved	translation	elongation	factor	P	(EF-P),	this	











Knockout	 of	 human	MINA53	 and	 NO66	 in	 Hek293	 using	 CRISPR/Cas9	 showed	 only	minor	
growth	defects	and	ribosome	profiles	also	 revealed	no	differences	compared	to	wild	 type.	
The	 reconstituted	 cell	 lines	 did	 also	 not	 show	 drastic	 effects	 on	 the	 proliferation,	 even	
though	 reconstituted	 protein	 expression	 was	 much	 higher	 than	 endogenous	 MINA53	 or	
NO66	expression.	Despite	these	observations,	both	proteins	are	described	to	be	involved	in	
cancer	 cell	 growth.	MINA5355-70	was	 reported	 to	be	upregulated	 in	different	 cancer	 types,	
NO66	plays	a	role	in	osteoblast	differentiation79	and	bone	formation	in	mice81,82.	
Their	 similarities	 concerning	 protein	 domain	 structure	 and	 crystal	 structure,	 ribosomal	
substrates,	 and	 subcellular	 localization	 might	 suggest	 a	 redundancy	 of	 both	 proteins.	





The	 special	 genomic	 situation	 of	 NO66	 and	 the	 question	 of	 redundancy	 of	 MINA53	 and	
NO66	led	us	to	a	genomic	and	phylogenetic	approach.		
Searching	 for	MINA53	and	NO66	 sequences	 in	different	organisms	 revealed,	 that	 some	of	
those	species	did	not	exhibit	MINA53	sequences.	Model	organisms	Caenorhabditis	elegans	
(C.elegans)	and	Drosophila	melanogaster	 (D.melanogaster)	only	encode	NO66,	the	same	 is	
true	 for	 other	 invertebrate	 species	 from	 arthropoda,	 mullosca,	 nematoda,	 and	 annelida.	
Suprisingly,	 the	 fresh-water	polyp	Hydra	 as	early	metazoan	animal	of	 the	phylum	Cnidaria	
posseses	both	MINA53	and	NO66	sequences.		
Expression	 of	 both	 Hydra	 NO66	 with	 GFP-tag	 in	 Hydra	 vulgaris	 showed	 a	 comparable	




in	Hydra	 vulgaris.	 This	might	be	 a	hint	 towards	 an	 adapted	or	 slighly	 changed	 function	of	
MINA53	 through	 out	 the	 evolution,	 whereas	 NO66	 might	 have	 kept	 the	 same	 function.	
However,	 this	 hypothesis	 needs	 further	 experiments.	 NO66	 function	 in	 C.elegans	 or	
D.melanogaster	 could	 be	 examined,	 also	 organisms	 harboring	 both	 proteins	 sequences	
could	be	analyzed	for	MINA53	and	NO66	protein	functions.	
	







Intronless	 genes	 are	 a	 characteristic	 feature	of	 prokaryotes,	 but	 still	 ca.	 9%	of	 the	human	
encoding	genes	consist	of	only	one	exon155.	All	histons,	around	50%	of	the	G-protein	coupled	
receptors	 (GPCRs)	 and	 several	 proteins	 involved	 in	 transcription	 and	 translation,	 are	
encoded	 by	 intronless	 genes156.	 Advantages	 of	 SEGs	 might	 be	 of	 economical	 nature.	
Generating	 mRNAs	 with	 introns	 would	 need	 more	 time	 and	 energy,	 splicing	 requires	
additional	 factors.	 On	 the	 other	 hand,	 intron	 containing	 genes	 would	 allow	 diversity	 in	
protein	products	by	alternative	splicing155-157.	
NO66	 might	 be	 a	 single	 exon	 gene	 to	 allow	 the	 cell	 to	 react	 quickly	 to	 changing	
environmental	or	stress	conditions.	This	might	change	the	hydroxylation	status	of	ribosomal	
protein	 RPL8,	 which	 could	 fine-tune	 translation	 in	 response	 to	 different	 stimuli.	




In	 addition,	 the	 phylogenetic	 analysis	 implies	 that	 MINA53	 could	 be	 the	 earlier	 invented	
protein	due	to	the	branching	of	ycfD	and	MINA53.	The	consistency	of	NO66	being	present	in	
all	studied	organisms	might	contradict	 this.	Others	suggest	ycfD	to	be	evolved	 into	NO666.	





A	 few	2OG	oxygenases	are	 reported	 to	 form	homo-dimers	or	 -multimers,	but	not	much	 is	
known	about	the	function	of	oligomerization.	
MINA53	 and	 NO66	 as	 well	 as	 bacterial	 ancestor	 ycfD	 have	 a	 very	 conserved	 domain	
structure	and	dimerize	 via	proposed	dimerization	domains6.	 For	MINA53	and	NO66,	 three	
amino	 acids	 in	 the	 dimerization	 domain	 could	 be	 identified	 which	 –	 if	 mutated	 -	 led	 to	
disruption	of	 the	homo-oligomerization.	 For	NO66	and	 substrate	RPL8,	 inhibition	of	NO66	
dimerization	also	disrupted	substrate	binding.	MINA53	triple	mutant	could	not	be	examined	
in	 substrate	 binding,	 but	 the	 cellular	 localization	 changed	 from	 nucleolar	 to	 an	 evenly	
distribution	 over	 the	 cell	 nucleus	 (data	 not	 shown).	 Therefore,	 for	 MINA53	 and	 NO66,	
dimerization	 seems	 to	 be	 essential	 for	 substrate	 binding,	 localization,	 and	 maybe	 for	
enzymatic	 activity.	 A	 change	 in	 localization	 controlled	 by	 homo-oligomerization	 has	 been	




oligomerization	as	 factor	determining	activity	 is	 the	oxygenase	 FIH,	 is	 reported	 to	be	only	
catalytically	active	in	the	form	of	a	dimer159.	Also	in	the	hypoxic	pathway,	prolyl	hydroxylase	
domain	 protein	 2	 (PHD2)	 displays	 the	 opposite	 catalytic	 function	 of	 dimerization.	
Dimerization	 in	 response	 to	 oxidative	 stress	 leads	 to	 the	 inactivation	 of	 the	 protein	 and	
thereby	the	hypoxic	response	pathway	is	activated160.	
	
OGFOD1	 as	 third	 human	 oxygenase	 modifying	 the	 ribosome	 directly	 is	 not	 reported	 to	








are	 dimethyloxalglycine	 (DMOG)	 or	 N-oxalylglycine	 (NOG)161.	 Both	 are	 unreactive	 2OG	
analogues,	 which	 are	 not	 released	 from	 the	 catalytic	 side	 of	 2OG	 oxygenases	 after	 the	
reaction	 and	 thereby	 inhibiting	 further	 catalytic	 activity.	 This	 way	 of	 inhibition	 is	 very	
unspecific	 as	 it	 targets	 nearly	 all	 2OG	 oxygenases,	 specific	 inhibitiors	 for	 single	 2OG	


















































































































































































































































actin-HRP	 sc-1616	HRP	 Santa	Cruz	 goat	 	 1:500	
CCNA2	(Cyclin	A),	clone	CY-A1	 C4710-.2ML	 Sigma	 mouse	 1:200		 1:500	








CDK1/Cdc2	p34	(17)		 sc-54	 Santa	Cruz	 mouse	 	 1:100	





Roche	 mouse	 	 1:500	
HA	Tag	 sc-Y11	 Santa	Cruz	 rabbit	 1:100	 	
M2	anti-FLAG	 F1804-200ul	 Sigma	 mouse	 	 1:500		
MINA53	 ab169154	 Abcam	 mouse	 	 1:300		





Abcam	 rabbit	 	 1:1200	
OGFOD1	 HPA003215		 Sigma	 rabbit	 1:500	 1:500	
RPS23	 ab57644	 Abcam	 mouse	 	 1:50	
TIA1	 sc-1751	 Santa	Cruz	 goat	 1:50,	
1:100		
	
UBF	(H-300)	 sc-9131	 Santa	Cruz	 rabbit	 1:200	 	
Isotype	control	for	Cyclin	A	(H-
432)	





































































































































































































































MINA53	 pLVTHM- PmeI/	 This	work	 Lentiviral	 Full	length	MINA53	
4	Material	
85	


































































































































































































































































































































































































































































































ScreenMinAEx1F	 GGTAGGTTTGCATTTCCTTACTGC	 Amplification	 of	 CRISPR/Cas9	
targeted	MINA53	locus	ScreenMinAEx1R	 CACCCTTGAGCTGATATGTGGC	















































































































































































































































































incubation	 of	 the	 bacteria	with	 the	 plasmid	 DNA.	 Following	 the	 heatshock,	 bacteria	were	
incubated	for	2	min	on	ice.		
Competent	 cells	 for	 electroporation	 were	 transformed	 following	 the	 instructor	 manual	
(BioRad).		
Independet	 of	 transformation	methode,	 bacteria	 were	 allowed	 to	 recover	 at	 37	 °C	 in	 LB	









To	 find	 the	 best	 conditions	 for	 expression	 of	 the	 protein,	 several	 growth	 conditions	were	
tested.	A	culture	of	bacteria	carrying	the	plasmid	of	interest	were	inoculated	and	incubated	
at	37°C	over	night	(O/N).	Per	condition,	100	ml	cultures	are	inoculated	from	the	O/N	culture	







1	 g	 bacterial	 pellet	 was	 resuspended	 in	 5	 ml	 50	 mM	 Tris-HCl	 pH	 7.5	 and	 lysed	 by	 three	
repeated	freeze-	(-80	°C)	and	thaw-	(37	°C)	cycles.	Lysates	were	centrifuged	at	13.000	rpm	
for	20	min	at	4	 °C	 to	obtain	soluble	protein.	The	resulting	pellet	was	resuspend	 in	50	mM	
Tris-HCl	(pH	7.5).	20	µg	of	protein	were	analyzed	with	the	soluble	protein	on	an	SDS	PAGE	by	
Coomassie	staining.	













Bacterial	 knockout	 strains	were	 generated	 using	 the	 „Counter-Selection	 BAC	Modification	
Kit“	from	Gene	Bridges	which	is	based	on	Red/ET	recombination.	
The	kit	provides	the	pRed/ET	plasmid,	which	carries	the	λ	phage	red	gba	operon	expressed	




Streptomycin	 resistance	 is	 a	 prerequisite,	 therefore	 in	 BW25113,	wild	 type	 rpsL	 gene	was	
replaced	by	the	rpsL150	gene	which	leads	to	a	streptomycin	resistance	due	to	a	K43R	amino	
acid	 substitution.	RpsL150	 gene	was	 PCR	 amplified	 from	 TOP10	 bacteria	 and	 recombined	
into	BW25113	carrying	the	plasmid	pRED/ET	(tet).	Following	the	kit	 instructions,	BW25113	
strain	 was	 transformed	 with	 the	 pRed/ET	 plamid	 carrying	 a	 ampicillin	 (ampR)	 resistance.	
After	 selection	 for	 ampicillin,	 bacteria	 were	 transformed	 with	 the	 linear	 PCR-amplified	
rpsL150	flanked	by	50	nucleotides	(nts)	homology	arms	to	target	the	rpsL	locus.	Subsequent	
activation	 of	 Red/ET	 recombination	 led	 to	 insertion	 of	 the	 rpsL150	 gene.	 Schematic	
procedure	 for	 strain	 generation	 is	 depicted	 for	 ycfD	 catalytically	 inactive	 mutant	 strain	
(BW25113	(rpsL150,	ycfD-H125A,	D127A)	(Figure	67).	BW25113	(rpsL150)	was	transformed	
with	 pRed/ET	 and	 used	 for	 generation	 of	 different	 bacterial	 genomic	 modifyed	 strains	
following	the	manufacturers	instruction.		






Figure	 67:	 Principle	 of	 introducing	 ycfD	mutations	 into	 the	 bacterial	 chromosome	 using	 Red/ET	mediated	
recombination	and	rpsL-based	counter-selection	 	 (Gene	Bridges	“Counter-Selection	BAC	Modification	Kit”);	
A)	 Engineered	 streptomycin-resistant	 strain	 is	 transformed	with	 the	 pRed/ET	 plamid	 carrying	 a	 ampicillin	
(ampR)	resistance,	B)	Bacteria	are	transformed	with	a	linear,	PCR-amplified	rpsL-neo/kan	cassette	flanked	by	
50	 nucleotides	 (nts)	 homology	 arms,	 in	 this	 case	 first	 and	 last	 50	 nts	 of	 ycfD,	 C)	 Activation	 of	 Red/ET	
recombination	 leads	 to	 insertion	 of	 the	 cassette	 replacing	 ycfD	 gene	 leading	 to	 a	 neomycin(neoR)	 and	
kanamycin	 (kanR)	 resistance,	 the	 additional	 copy	 of	 the	 dominant	 wild	 type	 rpsL	 gene	 leads	 to	 strep	
sensitivity,	D)	With	a	second	transformation,	PCR	amplified	linear	DNA	of	ycfD	with	the	desired	mutation,	in	











hm rpsL neo/kan hm
1. Transformation
hm rpsL neo/kan hm
1. Red/ET-Recombination













































































































































For	 synchronization,	 cells	 at	 30-50	 %	 confluency	 were	 grown	 with	 growth	 medium	
containing	 2	 mM	 thymidine.	 After	 17/18	 h	 incubation	 at	 37	 °C	 and	 5	 %	 CO2,	 cells	 were	
released	from	the	first	thymidine	block	by	removing	the	thymidine-containing	medium	and	
rinsing	 the	 cells	 two	 times	with	 growth	medium.	 Subsequently,	 cells	were	 trypsinized	and	
seeded	to	appropriate	cell	culture	dishes.		
6	 h	 after	 seeding,	 cells	 could	 be	 transfected	 using	 the	 appropriate	 amount	 of	 DNA	 and	
Lipofectamine®	2000.	The	second	thymidine	block	was	applied	after	10/9	h	by	addition	of	2	
mM	 thymidine	 to	 the	 growth	 medium.	 In	 case	 of	 transfection,	 cell	 growth	 medium	 was	
exchanged	 with	 medium	 containing	 2	 mM	 thymidine.	 Release	 of	 the	 second	 block	 after	
15/17	h	was	initiated	as	mentioned	above.		
	















HeLa	 cells	 grown	 to	 50–70	 %	 confluence	 on	 18	 mm	 diameter	 glass	 coverslips	 were	
transfected	 with	 expression	 constructs	 using	 Lipofectamin®	 2000	 according	 to	 the	















Light	 optical	 sections	 were	 acquired	 with	 a	 Leica	 TCS	 SP5-2	 confocal	 laser-scanning	
microscope	(Böttger	Lab,	Biocenter	LMU).	Fluorochromes	were	visualised	with	the	405	laser	
with	 an	 excitation	wavelength	of	 405nm	and	emission	 filters	 413	 to	 443nm	 for	DAPI.	 The	











All	 steps	 of	 the	 procedure	were	 carried	 out	 on	 ice.	 Transfected	 cells	were	 harvested	 and	
lysed	in	lysis	buffer	(see	4.12.1).	Lysed	cells	were	centrifuged	at	14000	g	for	10	min	at	4	°C	
and	 the	 resulting	 supernatant	 diluted	 with	 wash	 buffer	 1	 (see	 4.12.6).	 For	 subsequent	
analysis,	around	10	%	of	the	 input	were	spared	(Input	fraction,	„I“).	Proteins	not	bound	to	
beads	were	saved	for	subsequent	analysis	(„Flow	through	fraction“	or	„F“).	Elution	of	protein	
complexes	 („Beads	 fraction“,	 „B“	 or	 „Elution	 fraction“,	 „E“)	 was	 achieved	 dependent	 on	




















For	 recombinant	 IP,	 bacteria	were	 transformed	with	 appropriate	plasmids	 and	grown.	 For	
GST-immunoprecipitation,	 in	total	2500	µg	crude	bacterial	 lysate	was	mixed	and	incubated	





with	 the	 appropriate	 antibody,	 3	 µg	 antibody	was	 coupled	 to	 Protein	G	 Sepharose	 4	 Fast	
Flow	 (GE	 Healthcare)	 for	 2	 h.	 For	 immunoprecipitations	 after	 synchronization,	 1.5	 µg	
antibody	 was	 used	 for	 8x	 106	 cells.	 Subsequently,	 immunoprecipitation	 was	 carried	 out	














Fluorescence-2-hydrid	 assay	 (Chromotek)	 experiments	 were	 carried	 out	 following	 the	
manufacture’s	 protocol.	Differing	 from	 the	protocol,	 1.2	µg	GFP-bait	 and	1.2	µg	mCherry-
prey	DNA	with	 1.6	µg	platform	 reagent	were	 co-transfected	using	 Lipofectime	2000.	 Cells	













was	 carried	 out	 with	 the	 Macherey-Nagel	 „NucleoSpin	 Gel	 and	 PCR	 Clean-up“	 kit.	 PCR	
product	 and	 1	 µg	 of	 the	 cloning	 vector	 were	 digested.	 Afterwards,	 the	 vector	 was	
dephosphorylated	using	Calf	intestine	alkine	phosphatase	(New	England	Biolabs).	Ligation	of	
around	50	ng	gel-eluted	insert	and	10	ng	vector	was	carried	out	with	T4	ligase	(New	England	





















Guide	 RNAs	 (gRNAs)	 were	 cloned	 into	 the	 pSpCas9(BB)-2A-Puro	 (Addgene	 plasmid	 ID:	











Isolation	 of	 clonal	 cell	 lines	was	 achieved	 by	 serial	 dilution	 into	 96	well	 plates.	 Single	 cell	
clones	were	 allowed	 to	 expand	 and	 later	 screened	 for	 successful	 genome	 editing	 by	 PCR	
amplification	of	the	corresponding	DNA	loci.	
For	isolation	of	genomic	DNA,	0.1x	106	cells	were	used.	Cell	were	harvested	by	trypsination	















To	 insert	 DNA	 randomly	 into	 the	 genome,	 cells	were	 infected	with	 lentivirus	 carrying	 the	
construct	of	 interest	 in	 the	pLVTHM-T2A-CD2	vector	 (gift	 from	Krappmann	Lab,	Helmholtz	
Zentrum	München).	Lentivirus	was	produced	by	transfecting	2x	106	Hek293T	cells	with	1	µg	
pMD2.G,	 1.5	µg	pPAX	 (gift	 from	Krappmann	 Lab,	Helmholtz	 Zentrum	München),	 and	2	µg	
pLVTHM-T2A-CD2	with	insert	using	XtremeGene.	After	72	h,	virus	was	collected,	filtered	and	
target	Hek293	cells	were	 infected	 in	 the	presence	of	10	µg/ml	polybrene	by	spin	 infection	
for	 1.5	 h.	 Following	 centrifugation,	 the	 virus	 containing	 medium	 was	 removed	 and	 cells	
expanded.	
Positive	reconsitution	was	validated	by	SDS	PAGE	with	subsequent	Western	Blot	analysis	and	
immuno-staining	 with	 appropriate	 antibodies.	 Additionally,	 cells	 were	 analyzed	 for	 CD2-






































centrifuged	 for	 45	 min	 at	 100000	 rpm	 (TLA120.2	 rotor,	 Beckman	 Coulter).	 After	
centrifugation,	 supernatant	was	 removed	 immediately.	 The	 ribosomal	 pellet	was	 carefully	
resuspended	in	storage	buffer	on	ice	to	homogeneity.	Buffers	are	listed	in	4.12.10.2.	
The	resulting	supernatant	are	the	solved	ribosomes	and	was	measured	for	OD260	absorption.	





ice,	 the	 lysate	 was	 centrifuged	 at	 12.000	 g	 for	 10	 min	 for	 4	 °C	 to	 remove	 debris.	 The	
supernatant	was	loaded	onto	500	µl	of	30	%	sucrose	cushion	solution	and	centrifuged	for	16	
h	 at	 26000	 rpm	 (TLA120.2	 rotor,	 Beckman	Coulter).	 After	 centrifugation,	 supernatant	was	














sucrose	gradient.	 Following	ultracentrifugation,	 the	gradients	were	 fractionated	 from	top	 to	bottom	while	
continuously	recording	the	absorption	profile	at	λ	=	254	nm.	
	
Fractions	 were	 collected	 from	 top	 to	 bottom	 (Gradient	 Station	 ip,	 BioComp)	 while	
continuously	recording	the	absorption	profile	at	λ	=	254	nm	(Econo	UV	Monitor,	BIO-RAD).	





Hydra	 experiments	 were	 carried	 out	 with	 the	 help	 of	 Jasmin	Moneer	 in	 the	 Böttger	 Lab,	




2.4	 mg	 Gold	 particles	 (1.0	 µm	 diameter,	 BioRad)	 were	 coated	 with	 10	 µg	 plasmid	 DNA	




Animals	 were	 relaxed	 in	 2	 %	 urethane	 in	 hydra	 medium	 and	 fixed	 with	 4	 %	





Sequences	 were	 obtained	 in	 collaboration	 with	 Andreas	 Lengeling	 (The	 Roslin	 Institute,	
University	 of	 Edinburgh).	 Orthologes	 of	 NO66	 (RIOX1)	 and	 MINA53	 (RIOX2)	 genes	 were	
identified	 using	 Ensembl	 (http://www.ensembl.org/info/about/species.html)	 and	
EnsemblMetazoa	 (http://metazoa.ensembl.org/species.html)	 portals	 by	 employing	 pblast	
searches.	 The	 genome	 of	 each	 selected	 species	 was	 queried	 with	 the	 human	 or	 Hydra	
vulgaris	 RIOX1/Riox1	 (Q9H6W3	 and	 XP_002157896.3)	 and	 ROX2/Riox2	 (Q8IUF8	 and	































































































































































































































































































































































































































































































































































































































































































































































































load 2.6 units OD260 
of crude ribosomes
centrifugation
harvesting of gradient with 
detection of absorption 








































































































































































































































































































































































































































































































































































































































































































































































































matched	 to	 a	 single	 locus	of	 the	 selected	 species	 and	 the	 identified	protein	displayed	 the	







Dr.	 Evi	 Lengeling-Wollscheid	 (The	 Roslin	 Institute,	 University	 of	 Edinburgh)	 performed	 the	
sequence	 alignments	 and	 generated	 the	 phylogenetic	 tree.	 Therefore,	 JmjC	 domain	
sequences	of	MINA53	and	NO66	from	49	species	and	of	YcfD	(ecycfD),	the	ROX	protein	from	
Escherichia	 coli	 were	 subjected	 to	 a	 maximum	 likelihood	 analysis	 using	 the	 online	
phylogenetic	 tool	W-IQ-TREE	 (Version	1.5.4	at	http://iqtree.cibiv.univie.ac.at,	 Trifinopoulos	
et	al.,	NAR	2016;	PMID:	27084950).	 In	the	 IQ-Tree	webserver	the	 ‘Substitution	model’	and	
the	 default	 ‘Auto’	 settings	 were	 selected	 to	 determine	 the	 best-fit	 substitution	 model	
followed	by	tree	construction.	Within	the	‘Branch	Support	Analysis’	the	default	settings	of	an	
ultrafast	 bootstrap	 analysis	 with	 1000	 replicates	 was	 used,	 with	 maximum	 number	 of	











a	double	 thymidine	block.	Between	 the	 first	 and	 second	block,	 cells	were	 transfected	with	 indicated	GFP-
tagged	 proteins	 using	 Lipofectamine.	 Samples	 were	 taken	 after	 indicated	 hours	 after	 release.	 Cell	 cycle	
profiles	were	obtained	by	flow	cytometry	after	NUCLEAR-ID®	Red	DNA	stain	(ENZO	life	sicence,	ENZ-52406)	






Specimen 0h O1axa.fcs GFP-positive 48525
Specimen 2h O1axa.fcs GFP-positive 31005
Specimen 4h o1axa.fcs GFP-positive 50568
Specimen 6h o1 axa.fcs GFP-positive 27852
Specimen 7h o1axa.fcs GFP-positive 53982
Specimen 9h o1axa.fcs GFP-positive 50248
Sample Name Subset NameCount
Specimen 0h.fcs GFP-negative 2895
Specimen 2h.fcs GFP-negative 2580
Specimen 4h.fcs GFP-negative 13352
Specimen 6h.fcs GFP-negative 12851
Specimen 7h.fcs GFP-negative 22288
Specimen 9h.fcs GFP-negative 15874
Sample Name Subset Name



































Specimen 0h nls.fcs GFP-positive 27857
Specimen 2h nls.fcs GFP-positive 15670
Specimen 4h nls.fcs GFP-positive 19868
Specimen 6h nls.fcs GFP-positive 35312
Specimen 7h nls.fcs GFP-positive 37452
Specimen 9h nls.fcs GFP-positive 70167
Sample Name Subset Name Count
Specimen 0h O1.fcs GFP-positive 41771
Specimen 2h o1.fcs GFP-positive 29504
Specimen 4h o1.fcs GFP-positive 41997
Specimen 6h o1.fcs GFP-positive 41716
Specimen 7h o1.fcs GFP-positive 54308
Specimen 9h o1.fcs GFP-positive 62084
















score Name Description ratio	CCNA2-IP/control
P67870 2 54 CSNK2B Casein	kinase	II	subunit	beta Infinity
Q9HD26 2 55 GOPC Golgi-associated	PDZ	and	coiled-coil	motif-containing	protein Infinity
Q12834 2 67 CDC20 Cell	division	cycle	protein	20	homolog Infinity
P33552 3 82 CKS2 Cyclin-dependent	kinases	regulatory	subunit	2 1104.3
P01857 2 32 IGHG1 Ig	gamma-1	chain	C	region 407.7
Q13309 6 199 SKP2 S-phase	kinase-associated	protein	2 168.7
P20248 14 649 CCNA2 Cyclin-A2 106.2
P61024 3 101 CKS1B Cyclin-dependent	kinases	regulatory	subunit	1 76.7
A5YKK6 6 159 CNOT1 CCR4-NOT	transcription	complex	subunit	1 72.8
Q15369 2 32 TCEB1 Transcription	elongation	factor	B	polypeptide	1 63.7
O60343 5 159 TBC1D4 TBC1	domain	family	member	4 58.5
P61962 2 60 DCAF7 DDB1-	and	CUL4-associated	factor	7 42.7
P28749 12 440 RBL1 Retinoblastoma-like	protein	1 37.8
P63208 5 168 SKP1 S-phase	kinase-associated	protein	1 36.9
P30291 9 304 WEE1 Wee1-like	protein	kinase 35.1
Q9H211 3 94 CDT1 DNA	replication	factor	Cdt1 33.7
Q9BY12 6 174 SCAPER S	phase	cyclin	A-associated	protein	in	the	endoplasmic	reticulum 26.3
P24941 9 363 CDK2 Cyclin-dependent	kinase	2 26.0
Q92793 8 254 CREBBP CREB-binding	protein 23.4
P19474 7 211 TRIM21 E3	ubiquitin-protein	ligase	TRIM21 17.6
O75496 3 86 GMNN Geminin 15.5
P55209 2 46 NAP1L1 Nucleosome	assembly	protein	1-like	1 15.2
Q9H0U4 2 89 RAB1B Ras-related	protein	Rab-1B 14.6
Q09472 2 79 EP300 Histone	acetyltransferase	p300 14.4
P46782 3 125 RPS5 40S	ribosomal	protein	S5 13.7
Q6PJG2 5 170 ELMSAN1 ELM2	and	SANT	domain-containing	protein	1 12.7
P06493 7 310 CDK1 Cyclin-dependent	kinase	1 10.4
P61254 2 39 RPL26 60S	ribosomal	protein	L26 8.4
Q9Y3Z3 13 423 SAMHD1 Deoxynucleoside	triphosphate	triphosphohydrolase	SAMHD1 8.4
Q7Z2Z1 7 195 TICRR Treslin 8.2
Q04917 2 70 YWHAH 14-3-3	protein	eta 7.6
P13674 2 47 P4HA1 Prolyl	4-hydroxylase	subunit	alpha-1 5.8
P12268 4 130 IMPDH2 Inosine-5'-monophosphate	dehydrogenase	2 5.7
Q4VCS5 7 251 AMOT Angiomotin 5.6
Q15459 2 55 SF3A1 Splicing	factor	3A	subunit	1 4.7
Q14974 3 108 KPNB1 Importin	subunit	beta-1 4.4
P15927 2 72 RPA2 Replication	protein	A	32	kDa	subunit 4.2
P31946 2 47 YWHAB 14-3-3	protein	beta/alpha 4.0
Q9UJZ1 2 65 STOML2 Stomatin-like	protein	2,	mitochondrial 3.9
P05141 2 40 SLC25A5 ADP/ATP	translocase	2 3.9
Q71U36 10 408 TUBA1A Tubulin	alpha-1A	chain 3.7
P27694 6 154 RPA1 Replication	protein	A	70	kDa	DNA-binding	subunit 3.6
P48735 2 53 IDH2 Isocitrate	dehydrogenase	[NADP],	mitochondrial 3.6
P31939 2 57 ATIC Bifunctional	purine	biosynthesis	protein	PURH 3.5
P07437 2 459 TUBB Tubulin	beta	chain 3.5
P78527 10 266 PRKDC DNA-dependent	protein	kinase	catalytic	subunit 3.4
P61247 2 46 RPS3A 40S	ribosomal	protein	S3a 3.4
P13489 2 87 RNH1 Ribonuclease	inhibitor 3.2
P62081 2 36 RPS7 40S	ribosomal	protein	S7 3.1
P55060 2 86 CSE1L Exportin-2 2.9
Q04837 3 74 SSBP1 Single-stranded	DNA-binding	protein,	mitochondrial 2.6
P62258 9 374 YWHAE 14-3-3	protein	epsilon 2.5
P60174 7 203 TPI1 Triosephosphate	isomerase 2.5
O00571 3 82 DDX3X ATP-dependent	RNA	helicase	DDX3X 2.5
P31930 2 62 UQCRC1 Cytochrome	b-c1	complex	subunit	1,	mitochondrial 2.3
P07954 2 56 FH Fumarate	hydratase,	mitochondrial 2.2
Q13162 2 75 PRDX4 Peroxiredoxin-4 2.2
P63104 6 194 YWHAZ 14-3-3	protein	zeta/delta 2.1
Q92499 2 44 DDX1 ATP-dependent	RNA	helicase	DDX1 2.1
P60660 3 64 MYL6 Myosin	light	polypeptide	6 2.1
















P55795 2 353 HNRNPH2 Heterogeneous	nuclear	ribonucleoprotein	H2 77.98 88.12
Q7L014 6 189 DDX46 Probable	ATP-dependent	RNA	helicase	DDX46 68.95 2.76
Q9BYN8 2 64 MRPS26 28S	ribosomal	protein	S26,	mitochondrial 47.59 63.52
O00299 2 49 CLIC1 Chloride	intracellular	channel	protein	1 46.40 67.65
P49591 2 55 SARS Serine--tRNA	ligase,	cytoplasmic 31.58 38.92
Q15637 2 41 SF1 Splicing	factor	1 30.96 57.78
P20674 2 59 COX5A Cytochrome	c	oxidase	subunit	5A,	mitochondrial 30.67 42.04
Q86VP6 3 61 CAND1 Cullin-associated	NEDD8-dissociated	protein	1 22.18 18.08
P30520 2 58 ADSS Adenylosuccinate	synthetase	isozyme	2 18.87 25.95
Q8N543 9 224 OGFOD1 Prolyl	3-hydroxylase	OGFOD1 18.10 16.01
P49755 2 72 TMED10 Transmembrane	emp24	domain-containing	protein	10 16.82 20.95
Q15181 3 86 PPA1 Inorganic	pyrophosphatase 14.69 19.46
Q99497 3 75 PARK7 Protein	deglycase	DJ-1 12.45 15.62
P30048 2 68 PRDX3 Thioredoxin-dependent	peroxide	reductase,	mitochondrial 11.73 10.62
P62937 3 90 PPIA Peptidyl-prolyl	cis-trans	isomerase	A 11.18 12.62
P62273 2 56 RPS29 40S	ribosomal	protein	S29 11.02 12.37
P35080 2 60 PFN2 Profilin-2 10.35 18.36
P15927 2 46 RPA2 Replication	protein	A	32	kDa	subunit 10.05 9.10
P27797 8 222 CALR Calreticulin 10.00 11.56
O43663 2 50 PRC1 Protein	regulator	of	cytokinesis	1 9.53 7.95
O95983 2 53 MBD3 Methyl-CpG-binding	domain	protein	3 8.84 7.32
P51858 2 52 HDGF Hepatoma-derived	growth	factor 8.71 10.18
P60174 8 273 TPI1 Triosephosphate	isomerase 8.71 10.28
P67775 3 100 PPP2CA Serine/threonine-protein	phosphatase	2A	catalytic	subunit	alpha	isoform 8.70 9.20
P54819 2 43 AK2 Adenylate	kinase	2,	mitochondrial 8.69 11.52
P22234 5 126 PAICS Multifunctional	protein	ADE2 8.66 8.65
P22695 2 42 UQCRC2 Cytochrome	b-c1	complex	subunit	2,	mitochondrial 8.27 9.23
P61204 4 119 ARF3 ADP-ribosylation	factor	3 8.19 9.98
P33316 3 89 DUT Deoxyuridine	5'-triphosphate	nucleotidohydrolase,	mitochondrial 8.18 9.97
P19623 2 39 SRM Spermidine	synthase 8.16 9.07
P62736 2 329 ACTA2 Actin,	aortic	smooth	muscle 7.94 6.44
O15347 2 73 HMGB3 High	mobility	group	protein	B3 7.60 8.29
P52565 2 44 ARHGDIA Rho	GDP-dissociation	inhibitor	1 7.25 7.86
O14929 4 127 HAT1 Histone	acetyltransferase	type	B	catalytic	subunit 7.16 8.84
Q92688 2 71 ANP32B Acidic	leucine-rich	nuclear	phosphoprotein	32	family	member	B 7.07 7.46
O15355 2 44 PPM1G Protein	phosphatase	1G 6.35 6.91
P13797 6 202 PLS3 Plastin-3 6.10 6.92
P00505 2 68 GOT2 Aspartate	aminotransferase,	mitochondrial 6.06 7.30
P51148 2 62 RAB5C Ras-related	protein	Rab-5C 6.06 5.85
O76003 2 45 GLRX3 Glutaredoxin-3 6.03 7.34
P30086 2 65 PEBP1 Phosphatidylethanolamine-binding	protein	1 6.03 7.25
P07737 5 144 PFN1 Profilin-1 5.53 6.82
Q9NQT5 2 56 EXOSC3 Exosome	complex	component	RRP40 5.52 6.11
P13667 9 277 PDIA4 Protein	disulfide-isomerase	A4 5.43 6.61
Q92973 2 50 TNPO1 Transportin-1 5.40 11.07
Q52LJ0 2 93 FAM98B Protein	FAM98B 5.32 7.23
Q8WUM4 3 97 PDCD6IP Programmed	cell	death	6-interacting	protein 5.24 6.16
Q16630 4 83 CPSF6 Cleavage	and	polyadenylation	specificity	factor	subunit	6 5.19 6.02
P20618 2 57 PSMB1 Proteasome	subunit	beta	type-1 5.03 5.76
Q15185 3 82 PTGES3 Prostaglandin	E	synthase	3 5.03 5.54
O14980 4 119 XPO1 Exportin-1 4.86 4.93
P00918 2 39 CA2 Carbonic	anhydrase	2 4.84 5.45
P27694 3 95 RPA1 Replication	protein	A	70	kDa	DNA-binding	subunit 4.74 3.72
Q9BRJ2 2 36 MRPL45 39S	ribosomal	protein	L45,	mitochondrial 4.56 5.42
P13693 2 70 TPT1 Translationally-controlled	tumor	protein 4.55 4.91
Q9UBS4 3 92 DNAJB11 DnaJ	homolog	subfamily	B	member	11 4.54 6.26
P31150 2 43 GDI1 Rab	GDP	dissociation	inhibitor	alpha 4.53 5.06
Q9NY27 2 57 PPP4R2 Serine/threonine-protein	phosphatase	4	regulatory	subunit	2 4.53 5.74
Q9UNZ2 2 41 NSFL1C NSFL1	cofactor	p47 4.49 5.39
Q13405 2 67 MRPL49 39S	ribosomal	protein	L49,	mitochondrial 4.49 4.56
O95684 2 44 FGFR1OP FGFR1	oncogene	partner 4.46 5.00
P24666 3 68 ACP1 Low	molecular	weight	phosphotyrosine	protein	phosphatase 4.45 5.05
P15531 4 87 NME1 Nucleoside	diphosphate	kinase	A 4.41 4.84
O14737 2 73 PDCD5 Programmed	cell	death	protein	5 4.39 4.34
Q9Y5L4 2 63 TIMM13 Mitochondrial	import	inner	membrane	translocase	subunit	Tim13 4.39 5.01
P40925 2 38 MDH1 Malate	dehydrogenase,	cytoplasmic 4.34 4.05
P55209 6 227 NAP1L1 Nucleosome	assembly	protein	1-like	1 4.26 4.32
P07237 4 131 P4HB Protein	disulfide-isomerase 4.17 5.00
Q15365 3 180 PCBP1 Poly(rC)-binding	protein	1 4.13 4.02
Q9Y2L1 2 38 DIS3 Exosome	complex	exonuclease	RRP44 4.10 4.28
P63208 4 121 SKP1 S-phase	kinase-associated	protein	1 0.50 0.42
Q9Y4P3 2 58 TBL2 Transducin	beta-like	protein	2 0.50 0.46
Q96HS1 9 257 PGAM5 Serine/threonine-protein	phosphatase	PGAM5,	mitochondrial 0.50 0.47
Q15208 12 418 STK38 Serine/threonine-protein	kinase	38 0.49 0.49
Q9Y2W1 25 861 THRAP3 Thyroid	hormone	receptor-associated	protein	3 0.48 0.55
O14744 26 868 PRMT5 Protein	arginine	N-methyltransferase	5 0.47 0.46








Q16875 12 439 PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase	3 0.46 0.47
Q8TDN6 2 48 BRIX1 Ribosome	biogenesis	protein	BRX1	homolog 0.45 0.48
Q9Y3Z3 24 778 SAMHD1 Deoxynucleoside	triphosphate	triphosphohydrolase	SAMHD1 0.45 0.38
P35527 43 1377 KRT9 Keratin,	type	I	cytoskeletal	9 0.45 0.29
Q9BRP8 3 95 PYM1 Partner	of	Y14	and	mago 0.44 0.42
P62857 3 99 RPS28 40S	ribosomal	protein	S28 0.44 0.35
P16989 8 366 YBX3 Y-box-binding	protein	3 0.44 0.55
P98179 2 60 RBM3 RNA-binding	protein	3 0.44 0.44
Q9H211 5 149 CDT1 DNA	replication	factor	Cdt1 0.43 0.43
Q9UPP1 8 195 PHF8 Histone	lysine	demethylase	PHF8 0.42 0.35
P24941 7 291 CDK2 Cyclin-dependent	kinase	2 0.42 0.34
P67809 9 472 YBX1 Nuclease-sensitive	element-binding	protein	1 0.41 0.47
P04264 31 1183 KRT1 Keratin,	type	II	cytoskeletal	1 0.40 0.31
Q14681 7 265 KCTD2 BTB/POZ	domain-containing	protein	KCTD2 0.39 0.43
P35908 21 934 KRT2 Keratin,	type	II	cytoskeletal	2	epidermal 0.38 0.29
P13645 20 876 KRT10 Keratin,	type	I	cytoskeletal	10 0.37 0.32
Q9NXV2 7 323 KCTD5 BTB/POZ	domain-containing	protein	KCTD5 0.36 0.41
P23588 12 431 EIF4B Eukaryotic	translation	initiation	factor	4B 0.36 0.43
Q7RTV0 2 86 PHF5A PHD	finger-like	domain-containing	protein	5A 0.36 0.39
P02768 8 221 ALB Serum	albumin 0.35 0.29
P02647 2 70 APOA1 Apolipoprotein	A-I 0.34 0.27
P63220 5 169 RPS21 40S	ribosomal	protein	S21 0.34 0.31
Q02413 4 121 DSG1 Desmoglein-1 0.33 0.36
P46778 4 69 RPL21 60S	ribosomal	protein	L21 0.32 0.30
P09234 2 44 SNRPC U1	small	nuclear	ribonucleoprotein	C 0.32 0.18
P05109 3 62 S100A8 Protein	S100-A8 0.31 0.37
Q7Z353 2 39 HDX Highly	divergent	homeobox 0.31 0.51
Q8N5Z5 10 344 KCTD17 BTB/POZ	domain-containing	protein	KCTD17 0.29 0.33
Q96DR8 2 34 MUCL1 Mucin-like	protein	1 0.26 0.27
P07477 3 84 PRSS1 Trypsin-1 0.22 0.20
Q86YZ3 7 325 HRNR Hornerin 0.22 0.16
P31944 3 87 CASP14 Caspase-14 0.22 0.24
P06702 3 100 S100A9 Protein	S100-A9 0.18 0.26
P31025 2 51 LCN1 Lipocalin-1 0.16 0.07
Q9NZT1 2 102 CALML5 Calmodulin-like	protein	5 0.14 0.14
P81605 3 96 DCD Dermcidin 0.14 0.13
P25311 2 50 AZGP1 Zinc-alpha-2-glycoprotein 0.14 0.20
P29508 2 57 SERPINB3 Serpin	B3 0.12 0.22
Q6UWP8 2 94 SBSN Suprabasin 0.08 0.14




Figure	 73:	 Proteins	 with	 altered	 CCNA2	 binding	 behaviour	 identified	 in	 Flag-CCNA2	 IP	 with	 additional	















compared to endogenous 
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MINA53-KO#4,	 and	 Hek293	 NO66-KO#3	 ribosomes;	 two	 technical	 replicates	 of	 ribosome	 profiles	 from	 A)	
Hek293	 wild	 type	 (WT)	 cells,	 B)	 Hek293-OGFOD1-D2	 +/-	 cells,	 C)	 Hek293	 NO66-KO#3,	 and	 D)	 Hek293	
MINA53-KO#4;	the	positions	of	different	ribosomal	species	are	indicated.	
	



































































































































































































































































































































































































































































































































































































































































































































































































load 2.6 units OD260 
of crude ribosomes
centrifugation
harvesting of gradient with 
detection of absorption 









































































































































































































































































































































































































































































































































































































































































































































































































Figure	 75:	 Clustal	 omega	 alignment	 of	 NO66	 protein	 sequences	 from	 H.sapiens	 (Uniprot:	 Q9H6W3),	
M.musculus	 (Q9JJF3),	 D.rerio	 (A3KP59),	 X.laevis	 (A0A1L8G801),	 C.elegans	 (O01658),	 D.melanogaster	
(E2QD64)	 and	H.vulgaris.	 The	 protein	 domains	 JmjC	 (blue),	 dimerization	 (yellow),	winged-helix	 (green)	 as	








                                                                             
H.sapiens           184aa RRVLAELNR-------IPSSRRRAARLFEWLIAPMPPDHFYRRLWEREAVLVRRQDHTYYQGLFSTADLDSMLR
M.musculus          146aa QQVLTELNG-------IPSSRRRAARLFEWLLAPLPPDHFYRRLWEREAVLVRRQDRSYYEGLFSTADLDSMLR
D.rerio             87aa  DILLTDLAK-------VNNSRDRANRLFQWLIHPVQDKSFFRDNWEKKPILIQRQNADYYKGLFSTAEFDRILR
X.laevis            133aa NTVLQDLGK-------IHNSKARAASLFEWLISPLAPADFFRDVWEQKPVLIKRHNHEYYDGLFSTKEFDRILR
C.elegans           284aa -----PAVDFDKFPFTDEDSVVTSSRAFGFMISPCDVQTFFDKFYQSNVLVVRRKQPTYFGNLFSTARLGELLE
D.melanogaster      196aa GNNNNDEKETETIETHKADSVEEGRRVLQWILFPVQTKVFFKDFWEHTACLVQRSNPKYFQSMISFKMLDEILI
H.vulgaris          167aa NQEKNDITNEHSKNKIKNLSSLSGKELFNWVLAPISSERFFSEAWQKKPLFIKRRQPLYNTNWFSTKKLDKILR
                                             *   .   : ::: *     *:   ::    .::* :  *  . :*   :. :* 
H.sapiens           NEEVQFGQHLDAARYINGRRETLNPPGRALPAAAWSLYQAGCSLRLLCPQAFSTTVWQFLAVLQEQFGSMAGSNVYLTPP
M.musculus          YEDVQFGQHLDAARYVDGRRETLNPPGRALPAAAWSLYRAGCSLRLLCPQAFSPTVWQFLAVLQEQFGSMAGSNVYLTPP
D.rerio             NDDVQYGVNLDVTSYTNGKRETHNPPGRALPYTVWDFYESGCSIRMLNPQAFSSTVWQVLSVLQEKFGSMAGANVYLTPP
X.laevis            EDNVQFGVNLDVTSYTDGNRETHNPPGRALPLVVWDYFKNGCSLRLLNPQSFCGPVWNVLSVLQELFGSMVGANTYLTPA
C.elegans           KNHLEYGRNINIAQYKNGVRTTLNGQGRAYPQIVKQHLHNMCSVQLVNPQTYDDRIWYLCEVIQEQFGCFVGANTYLTPA
D.melanogaster      RHHLDFTVNVDVTTYKNGKRETLNPEGRALPPAVWGFYSDGCSIRLLNPSTYLIRLRQVCTVLQEFFHCKVGANLYLTPP
H.vulgaris          EKNVQYTKNLDIAVYRNGQRETLNHEGRAFPSVVWKFYEDGCSIRLLNPQIFAKSVHQLTSRLQEYFGCLVGSNVYLTPP
                     ..:::  ::: : * :* * * *  *** *  .       **:::: *. :   :  .   :** * . .*:* **** 
H.sapiens           NSQGFAPHYDDIEAFVLQLEGRKLWRVYRPRVPTEELALTSSPNFSQDDL--GEPVLQTVLEPGDLLYFPRGFIHQAECQ
M.musculus          DSQGFAPHYDDIEAFVLQLEGRKLWRVYRPRDPSEELALTSSPNFSQEDL--GEPVLQTVLEPGDLLYFPRGFIHQAECQ
D.rerio             GTQGFAPHFDDIEAFVVQLEGRKHWRVYNPRCEDEVLSLVSSPNFSQDEI--GEPVMDVVLEAGDLLYFPRGFVHQGDCL
X.laevis            DTQGFAPHYDDIEAFIVQLEGKKHWRVYSPRNSSEFLPQFSSVNFRDRDI--GEPILETVLEAGDLLYFPRGFIHQGDCL
C.elegans           GSSGFAPHWDEIDAFLLQVEGRKYWRVWAPESAEEELPLESSDNFTEDDMKGREPVFEGWIEKGDMIYIPRGYIHQARTD
D.melanogaster      NSQGFAPHYDDIEAFVIQVEGRKRWLLYEPPKKADQLARISSGNYDQEQL--GKPIIDEVLSAGDVLYFPRGAVHQAITE
H.vulgaris          GSQGFAPHYDDIEAFVIQLEGKKHWKLYPPRNTNEVLARYSSENMQEENL--GEPILNKVLEAGDTLYFPRGVIHQASTL
                    .:.*****:*:*:**::*:**:* * :: *    : *   ** *  : ::   :*:::  :. ** :*:*** :**.       
H.sapiens           DGVHSLHLTLSTYQRNTWGDFLEAILPLAVQAAMEENVEFRRGLPRDFMDYMGAQHSDSKDPRRTAFMEKVRVLVARLG-
M.musculus          DGVHSLHLTLSTYQRNTWGDFLEAVLPLAVQAAIEENVEFRRGLPRDFMDYMGAQHSDSKDPRRTAFMEKVRVLVARLG-
D.rerio             PDAHSLHITISSYQRNSWGDLMLKLMPAALEVAMEEDVEFRKGLPLDYLQYMGVQNSEKEDPRRDRFMAHIQGLMKKLV-
X.laevis            PDAHSLHITISSYQRNSWADLLEKILPAALQVAVEEDVEFRKGLPLDYLDYMGVQNTDLEDPRRGTFIQQVQSLVKKLA-
C.elegans           SKVHSLHVTVSTGRQWSFANLMEKVVPEAIGVLTDTRHKLRRGLPTGLFDMGGVIDL--DYSQEDHFVEKFKMVVDRHMS
D.melanogaster      EQQHSLHITLSVYQQQAYANLLETLMPMVLKKAVDRSVALRRGLPLHTFQVLGNAYKGNDCGSRKQLVENVQKLVTNYLM
H.vulgaris          EDSHSLHITISLYQKSSWGDYLEKLIPLALQKAISENVMFREGLPIDFSSFVGVSNSEKKCPERDTFVKTVKKLMEKLI-
                       ****:*:*  :: ::.: :  ::* .:    .    :*.***    .  *      .   .  ::  .: :: .   
H.sapiens           ------HFAPVDAVADQRAKDFIHDSLPPVLTDRERALSVYGLPIRWEAGEPVNVGAQLTTETEVHMLQDGIARLVGE-G
M.musculus          ------HFAPVDAVADQRAKDFIHDSLPPVLTDRERALSVHGLPVRWEAGEPVNVGAQLTTETQVHMLQDGVARLVGE-G
D.rerio             ------SFAPVDAAVDQKAKDFLHDCLPPLLTAEEKAGSVYGAPARWGDSEALDVAVELKSQTRIKLVRAGAARLCSD-G
X.laevis            ------GYAPVDAAVDQKAKNFLHDCLPPVLTPVEKSHSVHGAPVMWDNGQVKDDTIELEADTKIRLLRGGIARLCSE-G
C.elegans           MLRNLVADQLLESSVDSLAKEFMKQALPPRLTEQEKKLSVLGSSTNLLGD----DLVDFTARTKVRLIRRHTQRLLMESE
D.melanogaster      -----PSEDDIDEAVDQMAKKFQHEALPPIVLPSEEVRTVHGARSDADEQGNCVCDYKFNKKTSVRLLRANILRLVTESD
H.vulgaris          ------DYVEIDEAGDELVLDHMEEFQPPYYSSDDVECSVFSKDGFWDGEVRRHHKIEL--STELRLVRPGIVRVIPA-D
                              ::   *. . .. .:  **     :   :* .               .:   * :::::    *:     
H.sapiens           GHLFLYYTVENSRVYHLEEPKCLEIYPQQADAMELLLGSYPEFVRVGDLP------CDSVEDQLSLATTLYDKGLLLTKM
M.musculus          GRLFLYHTVENSRVYHLEEPKCLEIHPQQADAMELLLRSYPEFVRVGDLP------CDSVEDQLSLATMLYDKGLLLTKT
D.rerio             DTVHLYYTTENSRVYHKEASKSFEMKTEHIDAMEFLIHSYPKFVSVASLP------CETAEAKMSLAELLFEKGLIFTAE
X.laevis            DACLLYFSSNNSRIYHREEPKYMEIAAEHVEAIEYLIHSYPKYVPVGSLP------CDQEEDKLTLATILFEKGLVTTRE
C.elegans           DACFISHRINNSRLFEGRPEQIVEYPISGIDAYRVLSNSYPEWRTLYEIFSLRETKTKSRKENLAAIQLLFQIGVLLVKN
D.melanogaster      GSVRIYHHVDNGLDYCKYEPYFMEILPEEAKAVELLISAYPFYLTIDQLP------LESSARKIEVATALWEHGLLMTEK
H.vulgaris          TELQVYYSVENSRQYKEVPLRVLRFSLEDADLLEYFLFSYPAYVVVENAP------GDDI-HKVDVANRLYNFGILRSKV
                        : .  :*.  :       ..   .  .  . :  :** :  : .         .    ::     *:: *::    
H.sapiens           PLALN-
M.musculus          PLVPS-
D.rerio             PLTAQ-
X.laevis            QLKPLR
C.elegans           ------
D.melanogaster      PFK---
H.vulgaris          PLVHT-
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„Phylogenetic	 and	genomic	 analyses	of	 the	 ribosomal	oxygenases	Riox1	 (NO66)	 and	Riox2	
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